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Résumé 
 L'évaluation de l'asynchronisme mécanique ventriculaire sous stress a soulevé une 
attention importante en tant que facteur prédictif de la réponse au traitement de 
resynchronisation cardiaque (CRT). De plus, il semble exister une relation significative entre 
le devenir du patient et la présence d’asynchronisme au repos. Plusieurs méthodes 
échocardiographiques peuvent être utilisées pour évaluer l’asynchronisme. Cependant, parmi 
toutes les différentes méthodologies ou index existant dans ce domaine, aucun critère ne fait 
l’unanimité. Cette thèse étudie l'importance des techniques d'imagerie nucléaire dans le cadre 
de l’évaluation de l’asynchronisme cardiaque induit par le stress en utilisant trois différents 
modèles canins expérimentaux. 
 
 Le premier chapitre vise à examiner les effets du stress sur le synchronisme de la 
contraction du ventricule gauche (VG) en utilisant l'imagerie synchronisée de perfusion 
myocardique dans une cohorte canine normale. Le stress a été induit par différents niveaux 
d’infusion de dobutamine sur six sujets sains. Les paramètres hémodynamiques et 
l’asynchronisme ont été évalués par des mesures de pressions ventriculaires. L'analyse de 
phase sur l’imagerie s’est effectuée en utilisant un logiciel commercialement disponible (QGS) 
et un logiciel interne (MHI4MPI), basée sur le déplacement et l’épaississement des parois 
ventriculaires. L’augmentation de la concentration de dobutamine a démontré une 
amélioration de la capacité fonctionnelle et une réduction de l’asynchronisme ventriculaire. 
L’analyse de l’asynchronisme calculée à partir de l’épaississement de la paroi semble plus 
robuste et plus sensible que l’utilisation du déplacement des parois. (Salimian et. al., J Nucl 
Cardiol., 2014)  
 
 Le second chapitre étudie les différents paramètres d’asynchronisme au repos et à 
différents niveaux de stress dans un modèle de cardiomyopathie dilatée et à QRS étroit. Ce 
modèle a été créé sur dix chiens par tachycardie via stimulation de l'apex du ventricule droit 
pendant 3-4 semaines, permettant d’atteindre une fraction d'éjection cible de 35% ou moins. 
Le stress a ensuite été induit par une perfusion de dobutamine jusqu'à un maximum de 20 
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μg/kg/min. Les données hémodynamiques et l’asynchronisme ont été analysés par des mesures 
de pression ventriculaire et l’analyse de l’imagerie dynamique du compartiment sanguin. 
L’importante variabilité individuelle des sujets inclus dans notre cohorte empêche toute 
conclusion définitive sur la mesure de l’asynchronisme interventriculaire. Cependant, les 
différents niveaux de stress, même dans des intervalles rapprochés, ont démontré un effet 
significatif sur les paramètres hémodynamiques et l’asynchronisme. (Salimian et. al., J Nucl 
Cardiol., 2015) 
 
 La troisième section vise à déterminer si l’estimation du mode de stimulation optimal 
effectuée au repos demeure le choix optimal lorsque le niveau d’activité cardiaque s’intensifie 
pour des sujets avec bloc auriculo-ventriculaire (AV) et fonction ventriculaire normale. Cinq 
chiens ont été soumis à une ablation du nœud AV et des sondes de stimulation ont été insérées 
dans l'oreillette droite pour la détection, l’apex du ventricule droit (VD) et une veine 
postérolatérale du VG pour la stimulation. Cinq modes de stimulation ont été utilisés : LV pur, 
biventriculaire (BiV) avec pré-activation de 20 ms du LV (LVRV20), BiV pur, BiV avec pré-
activation de 20 ms du VD (RVLV20), VD pur. Des niveaux jusqu’à 20 μg/kg/min de 
dobutamine ont été atteints. Le stress a modifié l’étendue de l’asynchronisme de base et ce, 
pour tous les modes de stimulation. De plus, les effets physiologiques intrinsèques du stress 
permettent une évaluation plus précise de l’asynchronisme ventriculaire, diminuant la 
variabilité inter-sujet. Le mode de stimulation LVRV20 semble le mode optimal dans ce 
modèle, supportant l’utilisation de la stimulation bi-ventriculaire. 
 
Mots-clés: Asynchronisme ventriculaire mécanique, SPECT synchronisée de la perfusion 
myocardique, le stress de la dobutamine, SPECT synchronisée du compartiment sanguin, 
cardiomyopathie dilatée avec QRS étroit, thérapie de resynchronisation cardiaque, contraction 
homogénéité, bloc auriculo-ventriculaire et la fonction normale. 
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Abstract 
Assessment of ventricular mechanical dyssynchrony (MD) under stress has attracted a 
large amount of attention as a stronger predictor of response to cardiac resynchronization 
therapy (CRT) and as a parameter whose variation bears a greater relationship to clinical 
outcomes than resting-MD either in CRT candidates or another subset of patients. Several 
echocardiographic methods can be used to assess stress-MD. However, no standardized 
approach is currently used to explore stress-induced variations in inter- and intraventricular 
MD. This dissertation studies the importance of nuclear imaging techniques in assessing 
stress-induced MD variations by providing three different experimental canine models. 
 
 The first chapter sought to examine the impacts of stress on the left ventricular (LV) 
synchrony with phase analysis of gated SPECT myocardial perfusion imaging (GMPS) within 
a normal canine cohort. Stress was induced by different levels of dobutamine infusion in six 
healthy subjects. Hemodynamic and LV MD parameters were assessed by LV pressure 
measurements and phase analysis of GMPS using commercially available QGS software and 
in-house MHI4MPI software with thickening- and displacement-based methodology. The 
increase of dobutamine level was shown to be in accordance with the improvement of LV 
functional capacity and reduction of MD parameters. MD analysis based on wall thickening 
was more robust and sensitive than the global wall displacement. (Salimian et. al., J Nucl 
Cardiol., 2014)  
 
 The second chapter investigated the range of difference in inter- and intraventricular 
MD parameters from rest to various levels of stress in a dilated cardiomyopathy (DCM) and 
narrow QRS complex model. Ten large dogs were submitted to tachycardia-induced DCM by 
pacing the right ventricular apex for 3-4 weeks to reach a target ejection fraction of 35% or 
less. Stress was then induced by infusion of dobutamine up to a maximum of 20 μg/kg/min.  
Hemodynamic and MD data were analyzed by LV pressure measurements and gated-blood 
pool SPECT (GBPS) imaging. Individual differences in the magnitude and pattern of change 
in the various levels of stress precluded any definitive conclusion about interventricular MD. 
However, different levels of stress, even in close intervals, showed a significant positive 
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impact on hemodynamic and intraventricular MD parameters. (Salimian et. al., J Nucl 
Cardiol., 2015) 
 
 The third chapter sought to examine if the optimal pacing mode at rest could be the 
best one during the maximum stress level in terms of MD parameters in subjects with an 
atrioventricular (AV) block and normal function. Five dogs were submitted to AV node 
ablation and pacing leads were placed in the right atrium for sensing, in right ventricular (RV) 
apex, and in posterolateral LV vein for pacing in five modes of LV, biventricular (BiV) with 
20 ms of LV pre-activation (LVRV20), BiV, BiV with 20 ms of RV pre-activation (RVLV20) 
and RV pacing. Stress was induced by dobutamine infusion up to a maximum of 20 
μg/kg/min. Data analyses were the same as chapter one. Dobutamine stress changed the extent 
of resting-LV MD at all pacing modes. Intrinsic physiologic effects of stress resulted in more 
accurate MD assessment with lesser variability in subjects who underwent pacing. LVRV20 
was the preferred site of stimulation in this model rather than single-site pacing.  
 
Keywords: Ventricular mechanical dyssynchrony, gated myocardial perfusion SPECT, 
dobutamine stress, gated blood pool SPECT, dilated cardiomyopathy with narrow QRS, 
cardiac resynchronization therapy, contraction homogeneity, atrioventricular block and normal 
function. 
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Introduction  
In this chapter, the clinical motivation and a detailed background to mechanical dyssynchrony 
(MD), its applications and methods of assessment are provided. First, the main clinical 
motivation for the current thesis is identified in order to have a global view about the 
importance of the pacing and MD assessment. Next, the cardiac normal electrical activation 
sequence as an opening window to the ventricular pacing and cardiac resynchronization 
therapy is reviewed. Then, a detailed description is provided for better understanding of the 
MD concept, its applications, dynamic nature as well as quantification techniques. In the 
following, nuclear imaging techniques are overviewed both with the theory and practice 
vision. This section is helpful for the understanding of the overall methods used in this thesis. 
Next, the stress-induced modalities and the overview of the literature on dynamic left 
ventricular MD discourse are provided to add to the background knowledge of the stress-MD 
concept. Finally, the summary, objectives, and outline of remaining parts of the thesis are 
presented.  
Clinical motivation 
There are more than 200,000 Canadians and nearly 3 million individuals in North America 
living with permanent pacemakers or, cardiac rhythm devices.(1) Also, more than 250,000 new 
devices are implanted each year in North America because of an aging population and 
increased recommended indications for these devices.(1) The first pacemaker was implanted in 
1960 with the hope to save the life of a patient with atrioventricular (AV) conduction block.(2) 
Since then, not only it was served as a life saver in patients with bradycardia due to sinus or 
AV node dysfunction, but also since 2000, as a treatment option for increasing the patients’ 
2 
quality of life and expanding the survival rate in specific disorders (e.g. after cardiac 
transplantation or neuromuscular diseases) and cardiomyopathies (dilated or hypertrophic).(3) 
In the latter case, instead of treating or preventing the abnormal rhythms, pacing alters the 
activation sequence of the ventricles and influences the central hemodynamics in severe 
systolic heart failure (HF) and dilated cardiomyopathies.(3) Pacemaker implantation in these 
indications has been emphasized in previous guideline statements(3) since first, the indication 
for patients with sinus node dysfunction and AV block is inevitable thus it has been 
deemphasized and second, large number of new cases are diagnosed with HF each year 
(50,000 Canadians(4) and 915,000 Americans(5)). Despite major efforts have been made to 
identify the HF patients most likely to benefit from pacing therapy, still about 30% of 
recipients do not show any beneficial responses and ongoing efforts continue to develop more 
robust predictors.(6) One of the suggested predictors since 2000 has been the MD or timing 
disparity in ventricular regional contraction. However, it is not clear why the past efforts for 
optimizing the candidates by improving the characterization and quantification of MD have 
not resulted in substantial improvement in non-responders’ percentage. As it might be due to 
the lack of understanding about dynamic nature of MD and somehow the limitation of the 
previous MD assessment methods, the aim of this work is to apply the nuclear imaging 
techniques to understand how stress can modify the mechanics of the ventricles and how 
pacing affects the left ventricular contraction at stress condition.  
Normal electrical activation, a window to the artificial pacing 
Since having knowledge about normal cardiac electrical activation is of special importance in 
the context of cardiac mechanics and resynchronization, a quick review of the sequence of 
normal activation is provided here.(7) Cardiac conduction system consists of a group of cardiac 
3 
muscle cells within the cardiac walls which produce the action potential and conduct it 
throughout the cardiac chambers, causing the heart to depolarize and eventually contracts and 
pumps the blood out to the other organs. Under normal sinus rhythm, the action potential starts 
from the sinus node (first component of the system) in the atria and after activating the whole 
atria which take approximately 100 ms, by the inter-cellular conductions, reaches to the AV 
node (the second component of the system). In the normal heart, the AV node is the only 
electrical connection between the atria and ventricles. The impulse spends about 80 ms 
waiting to travel from the atrial side to the ventricular side in order to allow optimal 
ventricular filling before the ventricular contraction. Given the high resistivity (low 
conductivity) of the AV node tissue, it is susceptible to conduction impairments even a 
complete conduction block. In the following, the impulse reaches the His bundle of the 
Purkinje system (specialized conduction system of the ventricles) and then is conducted to the 
ventricles by the right and left bundle branches and eventually exits from both the anterolateral 
wall of the right ventricle (RV) and inferolateral wall of the left ventricle (LV). Electrical 
stimulation develops the action potential processes in the myocardial cells which are the 
sequence of ion fluxes through specific channels in the cell membrane. Myocytes exit the 
resting potential by depolarization wavefront and return the resting voltage after a short time 
by repolarization wavefront (for more information see reference (8)). Hence repolarization 
time is the sum of activation time (AT), the time between the earliest QRS deflection to the 
action potential upstroke, and the action potential duration (APD) or the action potential 
upstroke to 90% repolarization.(9)  
 Based on the observations in the isolated human hearts,(10) excitation synchronously 
happens in three LV endocardial areas, 0 to 5 ms after the start of the LV action potential: on 
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the anterior paraseptal wall just below the attachment of the mitral valve; central on the left 
surface of the interventricular septum and on posterior paraseptal about one-third of the 
distance from apex to base. These areas grow rapidly and merge in 15 to 20 ms, while the 
pattern of activation is mostly from the apex to the base through both the septum and free 
walls of the LV and RV, and transmurally from the endocardium to the epicardium.(10) 
Interestingly, endocardial cells are able to conduct the electrical impulses faster than the rest of 
the LV myocardium.(7) For the RV, endocardial activation starts near the insertion of the 
anterior papillary muscle 10 ms after the onset of LV activation.(7) The last parts of the RV and 
LV that become activated are the AV sulcus and the posterobasal area respectively.(7,10) In fact, 
the activation of the entire ventricles happens in a few ms (about 80 ms) in a homogenous and 
simultaneous way with the help of specialized Purkinje system; making the mechanical 
activation of the myocardium very coordinate.(7) 
 The aforementioned extraordinary valuable information on the excitation and 
activation of a normal heart and many other physiologic investigations opened the window 
into the use of artificial pacing which can mimic the AV activation sequence in patients with 
bradycardia and conduction disorders. In fact, if for any reason one of the components of the 
conduction system becomes dysfunctional, electric signals confront with functional block in 
their way through the system, finding new pathways through the working myocardium which 
makes the signal propagation to flow more slowly throughout the myocardium. This condition 
may create further structural and functional alterations which may ultimately result in the HF, 
a condition that impairs the ability of the ventricle to fill with or eject blood according to the 
needs of the body.(11) Thus, artificial pacing, as an inevitable therapy helps to improve the 
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function and the status of the HF patients and even may play a role as a life saver in patients 
with complete AV block.  
Ventricular pacing 
From more than 40 years ago, the ventricular pacing was introduced as a life saver in patients 
with complete AV block.(12) The site of the stimulation was first chosen to be the RV apex, 
given the ease of access, good fixation and a low capture threshold that RV pacing could 
provide.(12) However, after so many investigations on the long-term effects of the RV apical 
pacing, serious detrimental effects were proven to LV function(13,14) and structure.(15) These 
effects were mostly attributed to the late activation of the LV free wall.(12) Thus, less effective 
ventricular contraction by RV apical pacing and its long-term effects which were similar to the 
left bundle branch block (LBBB) status(12) shifted the interest toward finding alternative 
pacing sites (biventricular pacing) that induce a more physiologic activation sequence and 
ventricular performance. However, as Arenas et al.(12) recently suggested, it is not basically 
correct to fully extrapolate the detrimental effects of LBBB and the benefits of biventricular 
pacing, that will be explained in the next section to all patients who need RV pacing. Since, as 
they mentioned, the activation pathway, electromechanical delay, and the LV synchrony is 
completely different between these two conditions. But how could we determine whether a 
patient with AV block would benefit from an alternative pacing site? This problem has been 
further discussed and investigated in the third chapter. Hence, although ventricular pacing in 
the mode of RV apical pacing was first introduced only for AV block patients, several years 
later new pacing devices were also developed for further conduction disorders. 
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Cardiac resynchronization therapy  
In the mid-1990s, biventricular pacing device namely cardiac resynchronization therapy 
(CRT) was developed and found to be a clinically significant treatment in patients with end-
stage HF and intrinsic conduction delay.(16) CRT consists of the electric pre-excitation of two 
opposing sites of the heart: the RV apex or septum and the LV free wall which can be 
stimulated simultaneously or with a phase delay while the atrial electric activation is sensed or 
artificially paced and a programmed shorter AV delay time is used to achieve the ventricular 
capture.(6) Not only acute improvement was seen in hemodynamics after CRT implantation, 
but also chronic benefits such as improved LV function, symptoms, exercise capacity, and 
quality of life were proven at longer follow-ups.(17-20)  
 As it was apparently logic, CRT was first only targeted to a subset of patients who had 
a wide QRS duration(16) (e.g., LBBB); since simultaneous electrical stimulation of both 
ventricles in this treatment nearly compensated the later activation of the LV free wall relative 
to the RV and led to a practically synchronous ventricular contraction and therefore an 
efficient ventricular performance. However, using the QRS duration as an inclusion criterion 
in most of the early large clinical trials(17-20) for evaluation of response to CRT yielded some 
disappointed results.(16) Indeed, QRS duration poorly predicted the acute and chronic 
responses to CRT and about one-third of selected patients failed to show the expected clinical 
benefits.(16,21) Though, the interest was shifted toward other parameters that might better 
identify the CRT beneficiaries; since the CRT was (and still is) an expensive therapeutic 
option and so many procedural and follow-up complaints might occur from the patient side.  
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Mechanical dyssynchrony (MD)  
Ventricular MD is the timing delay in ventricular regional contraction and was proposed as an 
alternative for QRS duration in CRT patient selection.(16) The first documented use of MD as a 
parameter for prediction of response to CRT dates back to the early 2000s.(22) Primary studies 
found that MD better correlated with the acute(22) and chronic(23,24) CRT benefits and that it 
was an independent predictor of clinical events and survival in HF patients.(25,26) These 
findings, representing the assumption that mechanical rather than electrical dyssynchrony 
would better identify the CRT responders, initiated a cascade of research beyond the 
characteristics of MD, how prevalent it is, whether the method of its measurement is reliable 
and accurate, and if HF patients without a wide QRS duration are also appropriate for CRT.  
A true attempt toward understanding of MD 
Based on the results of studies including a variety of classified HF patients, MD seems to be 
quite common in HF patients neglecting the QRS duration. In another hand, as suggested by 
Kass in 2008, there is almost an epidemic of MD, which a majority of HF patients suffer 
from.(16) At this step, it is important to consider what exactly results in MD developing? As 
mentioned previously, homogenous, diffused and rapid electrical activation in the ventricles 
through the Purkinje system makes a coordinate and homogenous mechanical activation. But 
if there is a conduction disorder whether specific (e.g. LBBB) or non-specific, demonstrable in 
the ECG, it will cause a phase delay in the contraction of early and late activated regions. The 
electrical dyssynchrony is not always the reason of MD; there are still about 30% to 50% of 
HF patients, based on different studies, with a substantial amount of MD but without any 
widening or change in the QRS duration.(16,27,28)  Kass (16) listed three logical reasons in his 
excellent MD review for this case:  
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1) RV activation is so quick that in spite of LV dyssynchrony still a narrow QRS complex 
is recorded.   
2) Abnormal excitation-contraction coupling alters the kinetics of force development in 
one part of the heart compared with another.  
3) Ischemic damage, fibrosis, etc. make regional disparity in the myocardial contractility. 
Based on the fact that which mechanism is involved in HF patients with a narrow QRS 
duration, they might benefit (e.g. if the first reason is true) or otherwise be non-responders to 
CRT.   
 In spite of small studies(29) on a subset of patients with narrow QRS complex and some 
promising CRT results, overall, a recent multi-center randomized trial “Echocardiography-
Guided Cardiac Resynchronization Therapy” (EchoCRT)(30) reported no benefit in terms of 
number of HF hospitalization or death in patients with a QRS interval of < 120 ms.  Thus, it 
seems that electrical resynchronization is not an effective therapy when the MD is not resulted 
from the electrical dyssynchrony.(31,32) However, it is not clear why the past efforts for 
optimizing the CRT candidates by improving the characterization and quantification of LV 
MD have not resulted in any substantial improvement in clinical outcomes (still 30% non-
responders) even when further refining based on the ECG morphology (excluding no-LBBB 
patients) has been performed.(33) As it has been pointed out in literature, it might be due to the 
limitations of the MD assessment methods.(33) Also, the dynamic nature of MD may play a 
role per se. These two important constraints must be further investigated; since the MD not 
only has a critical role in the prediction of response to CRT but also has several other 
applications in today’s clinical practice that are discussed in the next section. 
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 As a note, although the current guidelines still recommend the CRT in patients with 
New York Hear Association (NYHA) class III or IV symptoms, LV ejection fraction (EF) ≤ 
35% and QRS duration ≥ 150 ms, the CRT indications have been expanded to include NYHA 
I-II, LVEF ˂ 40%, QRS > 120 ms, and chronic RV pacing secondary to AV block via 
randomized controlled trials in recent years.(34)  
MD applications 
The utility of the MD was shown to not being circumscribed to CRT optimization. Other 
potential clinical applications have been examined from about last 5 years. These applications 
include MD utility in prognostication and risk stratification of different subsets of patients(35) 
with ischemic(36) or non-ischemic cardiomyopathy,(37) implantable defibrillators,(38) and end-
stage renal disease.(39,40)  
 A classic parameter used to predict the future cardiovascular events or survival has 
been the LVEF which is a measure of global systolic function.(41) However, because of getting 
influenced by ventricular geometry and hemodynamic conditions, it could not be a sensitive 
indicator of ventricular function.(41) Among various parameters identified for better risk-
stratification, LV MD has been proposed as a unique indicator not only capable of determining 
the clinical outcomes in HF patients but also predicting major adverse cardiovascular events in 
asymptomatic individuals without evidence of heart disease.(41) The quantification of LV MD 
accordingly helps to identify the risk of HF progression in individuals who do not have the 
symptoms of any recognized heart disease and have a preserved EF.(42) This is of significant 
value since the optimal intervention period is always at early stages of the cardiac disease.  
 As previously studied, the age, increased LV mass, and lower regional myocardial 
perfusion are related to the superior extent of myocardial dyssynchrony in asymptomatic 
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individuals.(43) Also, LV MD was found to be closely linked to presence of coronary artery 
disease (CAD) risk factors (hypertension, diabetes, dyslipidemia, and obesity), QRS interval ≥ 
120 ms, history of CAD (primarily acute myocardial infarction), LV dysfunction (LVEF ˂ 45 
%), male sex, and presence of myocardial perfusion defects, especially of the fixed type in a 
retrospective study of 1000 patients with or suspected to have myocardial disease who 
underwent myocardial perfusion imaging.(42) 
Dynamic nature of MD 
MD is not a stable phenomenon; since the mechanical contraction is affected by different 
conditions and factors such as exercise, drug administration, inducible ischemia, pacing-
induced tachycardia and so forth; thus MD would change from time to time.(44) Dynamic LV 
MD has been assessed in different subset of patients, mostly in HF patients amenable to 
CRT,(45-47) and is thought to be a potential interfering mechanism for the lack of predictive 
value of resting MD.(44) Rocchi et al. was the first one that assessed this hypothesis and 
showed that exercise-MD is a stronger predictor of response to CRT than resting-MD.(48) Also, 
stress-induced variation in MD, whether positive or negative, has been shown to bear a greater 
relationship to clinical outcomes (death, heart transplant, assist device implantation, etc.) than 
resting-MD as assessed either in CRT candidates(49) or patients with dilated 
cardiomyopathy.(50) In fact, increased myocardial contractility during the exercise or 
pharmacological-induced stress (e.g. dobutamine infusion) may bring regional differences in 
myocardial contraction that is easily detectable at stress levels.(44,51)  
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Imaging techniques for quantification of MD 
Echocardiography 
So far, the echocardiography has been the most useful tool in cardiology for assessment of 
cardiac function and contraction abnormalities, since it is inexpensive and largely available.(52) 
Thus, it was also mostly used in the case of CRT patient selection, optimization of lead 
placement and device configuration as well.(52) Despite promising preliminary data from 
single-center studies in the value of CRT patient selection by echocardiography,(24,53,54) the 
PROSPECT trial (with a multi-center setting) announced that echocardiographic parameters 
assessing MD do not have enough predicting value to be recommended in routine clinical 
assessments.(55) This fact was more highlighted in EchoCRT(30) trial; since using even modern 
echocardiographic tools (speckle-tracking strain) in this trial could not change the belief 
stimulated by PROSPECT trial. Indeed, these methods are highly subject-dependent both in 
the case of image acquisition and analysis and because of limited repeatability and 
reproducibility cannot be reliable.(16,55) Probably, besides dynamic nature of MD, using 
echocardiography for quantification of MD has been resulted in a lack of a significant 
improvement in clinical outcomes (or reducing the number of non-responders).(33) As Van 
Everdingen et al. suggested, echocardiography is a friend of CRT but with known limitations 
and not in the patient selection but in other aspects like optimization of lead placement.(52) 
Cardiac magnetic resonance imaging  
Cardiac magnetic resonance imaging (MRI) as a non-invasive imaging modality provides 
excellent image spatial resolution and soft tissue contrast and does not have any ionizing 
radiation.(56) MRI as a gold standard for volumetric functional analysis, can also track the 
myocardial surfaces in 3-D space and analyze longitudinal, radial and circumferential strains 
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(i.e. myocardial deformation or length differences in the direction of long axis of the 
ventricles, across the wall (transmurally), and in the direction of ventricular circumference 
respectively) in a quite reproducible way using tagging techniques.(57) Thus, it seems to be 
quite functional for prediction of CRT response. However, MRI is not widely used in the 
measurement of MD because of high equipment cost, image acquisition complication, and 
lack of automated algorithms for image quantification.(51) 
Nuclear imaging modalities 
Nuclear cardiology techniques have been reliable alternatives to echocardiography for 
assessment of cardiac function since 1980.(51,58) First, planar radionuclide ventriculography(59) 
in 2-D, and then single-photon emission computed tomography gated blood pool (SPECT; 
GBPS)(60) in 3-D space were applied for better functional analysis and MD quantification. In 
both methods, the MD associated with endocardial motion can be analyzed by the variation of 
counts within the region of interest over the cardiac cycle.(51) Both planar and GBPS are 
promising in the assessment of not only LV intra- but also interventricular MD (phase delay 
between RV and LV contraction); because blood pool rather than myocardial wall imaging 
allows to a reliable volumetric estimation.(61) However, they cannot provide further 
information on the myocardial infarction, ischemia, and scar which has been shown to be a 
key determinant of response to CRT.(62) To make all this information in one session imaging, 
as Zhou et al.(63) so-called “one-stop shop”, gated myocardial perfusion SPECT (GMPS), over 
10 years ago,(64) and later positron emission tomography (PET) have been proposed for the 
purpose of CRT response prediction. Phase analyses of GMPS or PET assess the LV function, 
scar burden and location, LV site of the latest contraction, and MD from a single scan.(63) 
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Thus, depend on what information is needed based on each application and in which level of 
accuracy, the technique should be chosen.  
 Given the automated nature of phase analysis,(65) mostly determined by GMPS, it has 
shown excellent repeatability and reproducibility for quantification of ventricular MD.(66) This 
property facilitates the use of phase analysis for CRT patient selection process. In fact, the 
accuracy of predicting value of MD by phase analysis has been shown in previous single-
center acute(33) and chronic(58) studies in HF patients considering the current CRT inclusion 
criteria. However, prospective multicenter studies are warranted in this regard.   
 Overall, compared to other assessment methods, nuclear imaging is very promising for 
widespread clinical use in the CRT application; since it is routinely practiced, well 
standardized, and inexpensive.(63) Information about myocardial scar burden, viability, MD 
and global function in one-stop shop, automatic and highly reproducible fashion can be 
provided by these techniques.(63)  
SPECT imaging techniques for MD assessment 
The use of computer techniques in today’s nuclear medicine from the acquisition to 
processing, display, and data analysis has standardized the imaging and final image 
interpretation. It is the reason of an upward increase in utilization of nuclear medicine 
modalities (SPECT and PET) in today’s busy and demanding clinical environment.(67) The 
focus of the current thesis is on the SPECT imaging and techniques. In the following sections, 
two main cardiac SPECT techniques and the steps through which a 3D cardiac image is 
obtained will be described. 
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Gated SPECT myocardial perfusion imaging 
One of the most common methods for simultaneous evaluation of myocardial perfusion, 
function, and synchrony of contraction is GMPS. In this method, a radioactive-labeled 
substance which is mostly the Technetium-99m (99mTc) agents (sestamibi or tetrofosmin) is 
intravenously injected into a patient. After intravenous injection, the 99mTc agent is rapidly 
cleared from blood and uptakes by the myocardium. First-pass extraction and percentage of 
cardiac uptake for tetrofosmin and sestamibi are 50% and 1.2% versus 60% and 1.5% 
respectively.(68)  
   99mTc is a radionuclide with a half-life of 6 hours which emits the gamma rays in the 
range of 140.5 keV.(69) The energy is high enough not to be that much attenuated and low 
enough to be well detected by gamma cameras in nuclear medicine. The purpose of this 
radionuclide imaging is to obtain a 3-D image of the distribution of 99mTc within the LV 
myocardium.(70) In addition, the high counting statistics of 99mTc agents beside the use of the 
electrocardiographic gating makes a tomographic image set which allows for the visual and 
quantitative assessment of functional parameters such as myocardial motion and thickening.(70) 
To reach this aim, several steps are needed as gated SPECT acquisition, image reconstruction, 
filtering, image reorientation, segmentation, and final quantitative analysis. The following has 
described each of the steps respectively. 
Gated SPECT acquisition 
After the injection of a 99mTc-labeled agent to the patient and its uptake by the myocardium, 
gamma rays are emitted at the energy level that is high enough to be detected by the gamma 
camera without increasing the patient dose (there must be a balance between attenuation and 
detection). Although some of these photons undergo scatter or attenuation in the body, a 
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considerable amount can reach to the detectors of gamma camera consist of a scintillation 
crystal and an array of photomultiplier tubes (PMTs) and could be detected.(69,70) The collision 
of gamma photons to the scintillation crystal which is commonly the thallium-activated 
sodium iodide or NaI(Tl) crystal, leads to their conversion into the light photons 
(scintillation).(69) In the next step, light photons reach to the PMTs to be transformed into the 
electric signal and to be amplified and produce a strong electric current. The ultimate current is 
proportional to the energy of incident gamma ray and the amount of light from the scintillation 
process that reaches the PMT surface.(69) The final electric signals contain the acquisition data 
which is acquired in the form of tomography because the gamma camera head rotates around 
the patient in an orbital path and gathers several projection images(70) (in this thesis a dual-
head gamma camera was used with 64 projections dispatched on a 360˚ configuration). Using 
more than one camera head provides more counts for the image acquisition in the same 
acquisition time since at least 2 projections could be acquired simultaneously. Typically the 
procedure of the scan takes about 15–20 minutes in which the projections are acquired every 
3–6 degrees.(71) 
 If the signal gating is used for the acquisition, each R wave of electrocardiogram plays 
a role as a trigger which provides a time window (R-R interval) for selected set of projections 
from among many during the data collection. Then, R-R interval could be divided into 8 or 16 
equal segments and thus 8 or 16 projection images could be acquired corresponding to each 
portion of the cardiac cycle. Gating in several time frames helps to have a 4-D (3-D plus time) 
image which allows for the dynamic cardiac function assessments.(70) Also before 
reconstruction, summing all the projection images from different time intervals at each angle 
produces an ungated or static SPECT image from which perfusion can be assessed.(70) 
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Image reconstruction 
As mentioned in acquisition section, a 2-D projection image at each angle includes a series of 
counts or a projection profile related to the activities detected in the body. All the profiles 
known as sinogram are used to reconstruct a 2-D cross-sectional image of activity from the 
myocardium. For instance, all the profiles related to the apex section must be used to 
reconstruct the apex transaxial slice which is then stored in the first row of a 2-D matrix. Thus, 
if 16 frames per cardiac cycle and 64 projection angles at one complete patient rotation are 
used, data could be collected in 16 matrices of 64 × 64 pixels. Each matrix represents the 
maximal count in each myocardial segment from apex to base (row of the matrix) for each 
projection angle (column of the matrix).(67) In fact, collecting data at 64 different angular 
positions and summing all projection profiles, can provide enough information for 
reconstruction of a 2-D cross-sectional image at each time interval. To exclude extra-cardiac 
activity for the reconstruction process, the cardiac region can be manually selected. There are 
several approaches to reconstruct an image from the projection profiles as are discussed in the 
following.  
Simple Backprojection  
As it is apparent from its name, this approach is a basic and simple approach to image 
reconstruction. Projecting (or distributing) the data or counts recorded in a particular 
projection profile back uniformly on the pixels of an image matrix along its projection angle 
helps to have an approximate source distribution.(69) One of the drawbacks of this approach is 
the blurriness of the final image that even using an infinite number of views does not make the 
image completely clear.  
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Filtered Backprojection  
To improve the image quality in simple back-projection approach, filtering was suggested to 
be applied on the count profiles before the reconstruction.(69) Filtering process will be 
discussed in the next section in detail. However, what is important here is that to apply a filter 
in filtered back projection (FBP), the data are preferred to be in the frequency domain rather 
than the spatial domain. In this method, a ramp filter is used so as to selectively amplify high-
frequency components relative to low-frequency components.(70) Although filtering besides 
the back-projection process can eliminate the disadvantage of the previous approach, it still 
has some constraints. Filtering process in datasets with poor counting statistics can produce 
specific artifacts in the image. Once more, if the filtering in high spatial frequencies is used to 
eliminate those artifacts, it would further decrease the image resolution.(69) Also, the FBP 
algorithm requires additional data processing to compensate for some physical aspects of the 
imaging system and data acquisition, such as the limited spatial resolution of the detector and 
scattered radiation.(69) To consider these aspects directly into the algorithm and to decrease the 
probability of producing artifacts, iterative reconstruction approach came into the routine 
clinic with the support of higher computer speeds.   
Iterative Reconstruction Algorithms 
This approach uses several steps of estimation and comparison with the actual image to reach 
a successful true estimation of the image. A simple initial estimation could be even a blank or 
uniform image from which the intensities along each angle are summed up to yield a 
projection profile (inverse to the back-projection).(69) Doing so for all projections through the 
estimated image yields an estimated sinogram which will be compared with the actually 
recorded sinogram.  If the convergence has not been achieved in comparison process, it can be 
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adjusted based on the difference between the estimated and actual projections.(69) The update 
and compare process is repeated until the estimate approaches the maximum likelihood (ML) 
(usually in 10 – 15 iterations).(69) All the projection profiles or a complete sinogram must be 
produced at each iteration, and compared to the actual sinogram which is a long procedure. A 
method called ordered-subsets expectation maximization (OSEM) has been used to reduce the 
time of the conventional ML algorithm so that only a small number (or subset) of projection 
angles are used in the initial iterations and a larger number of projection angles are included in 
further refinements.(69,72) Iterative reconstruction can provide a more accurate image of the 
radioactive distribution within the body relative to the FBP.  
Filtering 
Even after iterative reconstruction, the quality of the image is not as good as expected; since 
there are several restrictions during the acquisition of gamma rays that lead to have generally 
poor statistics and high noise levels. These factors are the attenuation and scatter of gamma 
ray photons, the detection efficiency and the spatial resolution of the collimator-detector 
system.(71) Hence, post-processing or filtering is an important part of SPECT imaging to obtain 
a high-quality image. The choice of a filter for a reconstruction technique is always a trade-off 
between the extent of noise reduction and detail preserving.(71) In order to filter an image, it 
must be transformed from the spatial domain to the frequency domain or K-space (the 
coordinate system in the frequency domain) so that each 1-D projection profile from the object 
domain at each angle must be transformed into the 1-D K-space profile by Fourier function.(69) 
The Fourier analysis will be discussed in the following sections. In fact, it seems quite logical 
to filter the images based on the frequencies to highlight certain features or remove others.   
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 To reduce the statistical noise of a SPECT image, the smoothing or low-pass filters are 
commonly used, the inverse of high-pass filters such as ramp filters, which block the high 
frequencies and allow the low frequencies to remain constant in the image.(71) A number of 
low-pass filters are available for SPECT reconstruction but the most usual choice in nuclear 
medicine is the Butterworth filter. Given the ability to change not only the critical frequency, 
the frequency above which the filter starts to roll-off, but also the steepness of the cut-off, 
Butterworth filters are able to smooth the noise while preserving the image resolution.(71) 
Comparing Butterworth filter with Gaussian filter (a band-pass filter which allows certain 
range of frequencies to pass, more in the origin and less in the edges) and several other low-
pass filters in a study by cardiac phantom indicated that Gaussian filter was the best for 
contrast and signal-to-noise ratio while, Butterworth filter was the best for trade-off between 
contrast, signal-to-noise ratio, and defect size accuracy.(71,73) As a result, for qualitative 
analysis requiring high contrast and signal-to-noise ratio, Gaussian filter was suggested 
whereas for quantitative analysis requiring both image quality and defect size accuracy 
Butterworth filter was proposed.(71,73)  
 During the present thesis, quality of the cardiac images was important for the final 
segmentation processes and 4-D functional tracking and further analysis. Consequently, a 
ramp and a Gaussian function were multiplied to form the Fourier spatial frequency filter used 
in the FBP reconstruction process, when applicable, and only the symmetric Gaussian function 
was applied when the OSEM reconstruction was used.  
Reorientation 
Reconstruction of the image with either of the above methods provides a set of transaxial 
images (images perpendicular to the long axis of the patient). In this thesis, Siemens e-soft 
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the most important parts of the imaging for quantitative analysis such as perfusion or EF 
assessments and its precision is based on the precision of previous steps. There is a number of 
commercially available software for automatic segmentation of the LV which can produce a 3-
D LV image with the myocardial boundaries for further motion and functional analysis. Some 
of the well-known software in this regard include the Quantitative Gated SPECT (QGS; 
Cedars-Sinai Medical Centre), Emory Cardiac Toolbox (Emory University), and Corridor4DM 
(Michigan University). The details of each software method for segmentation and analysis are 
beyond the focus of the present thesis. However, I briefly remark some important points about 
the QGS software that is used throughout this thesis along with our in-house software in the 
following section.  
 Generally, if the aim is to assess the function or to calculate the volume and EF, the 
correctness of the estimated myocardial boundaries is of special importance. However, if the 
aim is only to evaluate the synchronicity (the coincidence of the motion or thickening) of the 
LV walls, it is not essential to find the actual positioning of the myocardial edges.(70) 
Quantitative Gated SPECT (QGS) software 
The QGS software uses the gated short-axis data sets after stacking them together to form a 3-
D image volume.(70) The first step involves the automatic segmentation of the LV myocardium 
based on several segmentation methods which are performed simultaneously in an iterative 
process to obtain a mask consistent with the expected size, shape, and location of the LV.(74) In 
fact, segmentation subdivides the image into its subsequent regions and the process is stopped 
when the LV is isolated. Various and complicated algorithms of segmentation are commonly 
used by engineers in the field of biomedical imaging based on the properties of intensity 
values either discontinuity or similarity. However, two main categories can be defined for 
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 To be sure of the first estimated mid-myocardial surface, it is fitted to an ellipsoid and 
previous procedure of placing the original coordinate system or center of mass along the 
ellipsoid’s long-axis and sampling is iteratively performed until the long-axis angular variation 
is less than 0.5 degree.(74) The count profiles from sampling the center of the final ellipsoid 
then are fitted to asymmetric Gaussian curves. The peak of Gaussian curves represent mid-
myocardial surface, while the endocardial and epicardial surfaces are determined by the 
calculation of Gaussian standard deviations, and the valve plane is determined by fitting a 
plane to the most basal myocardial points.(70) 
 The important matter at this point is the preservation of myocardial mass throughout 
the cardiac cycle which is imposed to the algorithm as a constraint. Once all the myocardial 
surfaces are calculated for each gating interval, quantitative analysis for LV cavity volumes 
can be performed. Multiplying the individual voxel volume by the number of voxels contained 
in the 3-D space between the endocardium and the valve plane yields the LV volume.(70) 
Based on calculating at end-diastole or end-systole, the volume would be the largest or 
smallest one from which the LVEF is derived as following:  
ܮܸܧܨ = ܧܦܸ − ܧܸܵܧܦܸ × 100 
(1) 
Where, the EDV and ESV stand for end-diastolic and end-systolic volumes respectively.  
Left ventricular synchrony parameters (QGS) 
QGS software added a phase analysis plug-in option in 2008 and introduced several 
parameters for ventricular synchrony measurements. All of these parameters are used in 
synchrony assessments throughout the present thesis.  
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 The QGS considers several spatial sampling points along the mid -myocardial surface 
and tracks the local maximum myocardial counts at each time interval. This creates a 
unidimensional array that represents a time-varying or periodic function. The number of 
counts varies with time, meaning that the counts increase at end-systole and decrease at end 
diastole and this happens cyclically. The QGS takes advantage of this periodic function by 
transforming it into the frequency domain to be able to work easier and more efficient with the 
sinusoidal signal in this domain. Using 8 or 16 frames per cardiac cycle is insufficient to have 
a continuous sinusoidal curve. QGS uses the first harmonic of Fourier function to increase the 
temporal resolution and to replace the discrete curves by the continuous ones.  
 The characteristics of a continuous sinusoidal signal during a cardiac cycle in the 
frequency domain can be determined by first, the phase angle which is the timing of 
mechanical contraction, the basis of all synchrony parameters, and second, the amplitude 
which is the magnitude of contraction or representative of regional stroke volume. In fact, the 
amplitude is only used by the algorithm to eliminate phase measurements that their 
corresponding amplitudes are considered too low to yield accurate measurements.(65) As it has 
been reported, around 5% of the samples with lowest amplitudes across the sampling region 
are automatically removed from the QGS analysis; since phase measurements are inaccurate 
for signals with low temporal variations.(65) 
 Once the phase signals are calculated for all the sampling points, a histogram of the 
distribution of those phase angles can be displayed in the software (Figure 3). On the basis of 
the whole-ventricle, wall-based, vessel-based, and segment-based statistics, phase histograms 
can be displayed and multiple global and regional LV synchrony parameters can be extracted 
from these histograms.(65) The mean and standard deviation are calculated as a routine part of 
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not.(79) Using the entropy hence, the actual randomness of the contraction could be determined 
within the region when the synchrony of contraction is diminished. The simplest and most 
common approach for entropy measurement is the histogram-based estimation via the 
following formula:(79) 
ߝ = −∑ ௜ܲ
ெ௜ୀଵ × logଶ( ௜ܲ)
logଶ(ܯ)  
(2) 
in which M represents the number of histogram bins and Pi is the frequency of the occurrence 
of phase angle i. Thus, the entropy is the number of measured phase angles that fall within bin 
i divided by the total number of bins or phase measurements in the histogram in a logarithmic 
form ranging from 0 to 1. In the ventricular synchrony assessments, if only one phase value 
exists in the histogram, entropy would be equal to zero and synchrony of contraction would be 
at maximum level.(65) We take benefits of all mentioned QGS synchrony parameters to assess 
ventricular mechanical synchrony under stress in our experimental models. 
MHI4MPI software 
The MHI4MPI is a fully automated in-house algorithm that assists in the diagnostic evaluation 
of mechanical synchrony in gated myocardial perfusion SPECT by segmentation of the LV 
and computation of the synchrony of wall contractions.(80) Although the QGS software is 
valuable on its own in segmentation and phase analysis, it does not consider the amplitude of 
contraction in its computations. However, besides the phase of contraction, the amplitude or 
the magnitude of wall contraction is important in wall thickening or motion abnormalities, 
since a dyssynchronous wall contraction with greater magnitude can more affect the entire 
contraction efficiency.(81) MHI4MPI algorithm takes both the phase and amplitude of 
contraction into account in its wall contraction synchrony analysis.(80)  
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 The second step consists of creating the surfaces for the myocardial limits (endocardial 
and pericardial surfaces) and applying a deformable dynamic surface algorithm (4D-Snake) in 
the gated images. Again external and internal forces are carried out sequentially in an iterative 
process on the mid-myocardium and two other surfaces. The algorithm will search along the 
normal to the endocardial and pericardial surfaces to find the zero crossing of the Laplacian at 
each frame.  
 The Laplacian technique is the most common approach for the edge-detection in 
nuclear medicine which is suitable for the objects with clear or sharp boundaries in radiotracer 
uptake.(69) Laplacian is defined by the second partial derivative of the function or pixel value 
with respect to the spatial coordinate x, y, and z in 3-D.(69) The point at which the Laplacian 
crosses zero reflects an edge, since it represents a high rate of change between neighboring 
pixel values.(69) Despite the fact that with limited SPECT resolution, this technique does not 
permit to an exact estimate of the wall thickness, it is good enough to correctly position the 
myocardial walls which are coherent in the structure. The actual positioning of the edges is not 
necessary since the goal is only to obtain the phase analysis of wall contractions, not the 
volumetric analysis. 
 Besides the previously described smoothing internal forces and the basal plane 
restrictions, the three surfaces are kept close to one another and a unique basal ring is forced 
on all three surfaces (Figure 5). Finally, to make sure that the movements are smooth and 
continuous, temporal forces are used to remove high-frequency harmonics on each vertex.   
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circumference with a specific size (radius), speed, and starting angle; then the combined 
position of all the cycles yields the final signal with amplitude, frequency and phase 
characteristics respectively (Figure 7).(83) Circular statistics help us understand the sinusoidal 
(time-activity) signals and final parameters that will derive from the Fourier transform. For 
this reason, some detail has been discussed here on the subject.  
 If you imagine the starting point to be the x-coordinate in a polar coordinate system, 
regular exponential growth continuously from the x-coordinate along the circumference with a 
certain rate closely simulates the movement of a signal in a cyclic way with a specific phase 
(starting point), amplitude (the radius of the circle) and frequency (how fast spins around the 
circle) (Figure 7). Therefore, a signal (maximum count change at a vertex of mid-
myocardium), appearing as a point in the circle, moves x radians towards the imaginary 
dimension in an exponential mode to get to -1 (half of the cycle) and then continue to finish 
the cycle. This is exactly what Euler’s formula  ݁௜గ = −1  means(83) and the Fourier transform 
is all about these to transform the time-activity curves as discrete curves containing maximal 
counts at different time frames (points at different places in circle circumference) into 
continuous sinusoidal curves. The formula is as following: 
ܨ௞ = ෍ ௧݂	݁ି௜ଶగ௞
೟
ಿ
ே
௧ୀଵ
 
(3) 
Which means: to find the signal (maximum count change for a vertex in the mid-myocardium) 
in a particular frequency (ܨ௞), spin (݁ି௜) the signal backwards ( ௧݂) around the circle (2ߨ) at 
that frequency (݇) and average ( ∑ 	೟ಿே௧ୀଵ ) a bunch (ܰ) of points (number of gates, ݐ) along that 
path (a cardiac cycle). This is a simple and informative interpretation of Fourier transform 
proposed by Stuart Riffle(84) which has been linked to our discourse. 
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As it has been shown in Figure 7, spinning around the cycle (݁௜ఏ) in degree from the x-
coordinate for each signal point gives exactly the same result as to adding up the real and 
imaginary parts (cos ߠ + ݅ݏ݅݊ ߠ) of the x-y coordinates for that specific signal point. (83) 
݁௜ఏ = cos ߠ + ݅ݏ݅݊ ߠ (4) 
Hence, the Fourier transform can be rewritten and simplified as the sum of cosine (R: real) and 
sine (I: imaginary) functions: (85) 
ܴ௞ = ෍ ௧݂ cos 2ߨ݇
ݐ
ܰ
ே
௧ୀଵ
 
(5) 
ܫ௞ = ෍ ௧݂ sin 2ߨ݇
ݐ
ܰ
ே
௧ୀଵ
 
(6) 
ܨ௞ = ෍(ܴ௞ − ݅ܫ௞)
ே
௧ୀଵ
 
(7) 
Again as it has been shown in Figure 7, with having the real and imaginary components of the 
right angle triangle, the hypotenuse or the amplitude (A) and the angle from the positive real 
coordinate or the phase (θ)	of signal point at each time interval can be measured as following: 
ܣ = ඥܴଶ + ܫଶ (8) 
θ = tanିଵ ܫܴ 
(9) 
Hence, the phase and amplitude which can be described by complex numbers made of real and 
imaginary components are the bases of all ventricular synchrony parameters produced by any 
software in this field. 
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The efficiency is of amplitude domain, it thus represents the portion of amplitude that 
is in the direction of the mean phase in a complex plane. Therefore, evaluating the average 
efficiency relative to the average amplitude gives us the magnitude of positive or efficient 
contraction that contributes to the stroke volume and ejection of blood out of the chamber. The 
latter concept is called contraction homogeneity index (CHI) as following: 
ܥܪܫ = ܧത̅ܣ 
(11) 
Based on the type of signal used for CHI calculation, it could be defined as thickening 
homogeneity index (THI) or displacement homogeneity index (DHI) (the proportion of wall 
thickening or displacement that is in synchrony with the average signal). Overall, efficiency 
lets us know what is happening locally while CHI gives us a global idea of how much 
synchrony or efficiency there is in the LV myocardium. In our point of view, evaluation of the 
amplitude is significantly important in mechanical dyssynchrony assessments; since looking 
only at the phase of contraction does not respond to the question that how much a region 
contributes to the stroke volume or total thickening. Also, as previously mentioned, a 
dyssynchronous wall contraction with greater magnitude can more affect the entire contraction 
efficiency. The amplitude will be even more functional in predicting the response to CRT. In 
our opinion, if a region is off-phase but it has the amplitude even negative, it might be possible 
to be resynchronized. However, an off-phase region with no amplitude or movement and thus 
no contribution to the contraction may not answer to the resynchronization therapy.  
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surface. The motion is analyzed by projecting the 3-D displacement vector along the variance 
vector with the positive direction defined as pointing outside of the mid-myocardium.(80) With 
these displacement signals, the DSLD and DHI can be calculated.  
Gated blood pool SPECT 
As previously mentioned, the most convenient way to assess the LV function, dynamics, and 
dyssynchrony in 3-D format is to use GMPS imaging with the administration of 99mTc labeled 
radiopharmaceuticals. However, in the case of having many defects in myocardial walls, 
evaluation of LV function and dyssynchrony may be interrupted. Also, the appraisal of RV 
function and inter-ventricular dyssynchrony is sometimes of special interest in the ventricular 
analysis; but perfusion images do not represent this information. Instead, gated blood pool 
SPECT (GBPS) can provide a more accurate estimation of right and left ventricular function 
without any geometric assumption for volumetric analysis.(70) Also, either intra or inter-
ventricular dyssynchrony parameters could be performed in GBPS based on wall motion 
analysis.  
The radiotracer in GBPS is yet again 99mTc that should be labeled with red blood cells 
of the patient. Thus, as it is apparent from the name of the imaging, the blood pool within the 
cardiac chambers can be imaged in this technique. All the procedures for the perfusion 
imaging such as acquisition, image reconstruction, filtering, reorientation, segmentation, and 
phase analysis could be performed in an identical manner for the GBPS imaging. The only 
difference is the segmentation of the region of interest which in the case of perfusion imaging 
is the myocardial wall and in the case of blood pool imaging is the endocardial-blood interface 
for both the right and left ventricles. Then in phase analysis section, a 3-harmonic inter-
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correlation of the RV and LV time-activity curves is used to compute the phase differences 
between ventricular chambers (inter-ventricular delay).  
Overall, all the final synchrony quantifications in both techniques depend on the 
quality of the raw projection data. Therefore, some factors during acquisition such as an 
inadequate number of counts, improper gating or positioning of the rotating camera and 
excessive motion of the patient can affect the final quantification process.(70) Also, the final 
quantifications depend on proper processing of the raw data during the image reconstruction 
and reorientation.(70)  
Cut-off values for phase analysis parameters 
As mentioned previously, the MD assessment is of special importance in the prognostication 
of a variety of cardiac dysfunctions mostly in the field of CRT. The GMPS as an automatic 
and reproducible imaging technique provides not only the MD parameters but also as a “one-
stop shop” technique, the perfusion, function and the presence, extent, and location of scar 
tissue. While these advantages have led to the growing use of GMPS in routine clinical 
practice once the MD assessment is essential, some questions have raised about the cut-off 
values of GMPS phase analysis parameters for normal versus electrical and/or mechanical 
cardiac dysfunctions. There are number of studies including control groups that have 
compared different parameters of phase analysis. However, no cut-off values have been 
provided in those studies.(66,86-89) 
In a recent study by Romero-Farina et al.,(90) the cut-off values for a control group 
versus patients with electrical and mechanical dysfunctions were proposed that are 
summarized in Table 1. This valuable study was performed prospectively with the recruitment 
of 150 normal subjects and 305 patients of whom 121 patients had mechanical cardiac 
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dysfunction such as dilated cardiomyopathy and myocardial infarction and 63 patients had 
electrical conduction disorders. The criteria of being normal were as following: having no 
history of CAD, normal resting electrocardiogram (sinus rhythm, QRS < 120 ms), no 
perfusion defect, and gated-SPECT EF > 50% which was the same criteria used in the 
previous studies including control groups for phase comparisons as cited in Table 2. As a note, 
the normal values of the phase parameters in different published studies are not exactly the 
same, maybe because of using different methodologies.  
In the study performed by Romero-Farina et al.,(90) a linear trend was seen between the 
extent of myocardial disturbance and the value of mechanical dyssynchrony parameters so that 
the amount of MD significantly increased from the normal to the electrical conduction 
diseases, mechanical cardiac diseases and both the electrical and mechanical diseases 
respectively. Although this study could provide an idea of group differentiation between 
different patients’ categories, as authors believe, a prospective clinical trial is needed to assess 
the cut-off values for MD parameters especially in the case of response to CRT. 
 
Table 1. Different cut-off values of phase parameters between normal subjects and 
patients with conduction and mechanical disorders (Romero-Farina et al. 2015). 
Group differentiation Cut-off for phase SD Cut-off for bandwidth 
Patient/normal >18.4 >51 
Mechanical/electrical disorder >26.1 >70 
With/without criteria of CRT  >40.2 >132 
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Table 2. Mean standard deviation and bandwidth in different control groups derived in 
different studies 
Authors Subject Number 
(F/M) 
Post 
stress/rest 
If 
categorized 
Standard 
deviation 
Bandwidth 
Trimble et al.(87) 
2007 
157(75/82) Post stress - 15.7 ± 11.8 42 ± 28.4 
Chen et al.(86) 2008 90 (45/45) Post stress F (45) 11.8 ± 5.2 30.6 ± 9.6 
M (45) 14.2 ± 5.1 38.7 ± 11.8 
Trimble et al.(66) 
2008 
50 (10/40) - - 8.6 ± 2.9 27.9 ± 8.9 
Atchley et al.(88) 
2009 
75 (50/25) Post stress - 8.8 ± 3.1 28.7 ± 9.3 
Chen et al.(89) 2011 30 (19/11) Rest - 7.6 ± 2 26.1 ± 7 
Romero-Farina et 
al.(90) 
2015 
150 (75/75) Rest All 12.2 ± 4.9 36.5 ± 12 
F 11.4 ± 4.6 34.2 ± 10.7 
M 12.9 ± 4.9 38.7 ± 12.9 
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Stress-induced modalities  
Exercise stress  
Dynamic stress testing has been an established clinical test mostly in the diagnosis, treatment, 
and prognosis of CAD.(91) However, it is also used for risk stratification after myocardial 
infarction and before non-cardiac surgical procedures, identification of viable myocardium in 
patients with LV dysfunction, predicting the recovery of LV function after coronary 
revascularization,(92) and assessment of MD for using in a number of applications as 
previously mentioned. Since the exercise stress testing is widely available and is less 
expensive than the pharmacologic stress, it is more preferable and if applicable, it can help to 
draw a link between the physical activity and inducing abnormalities.(92) The hemodynamic 
changes over the peak exercise have been well explained by Rallidis et al.,(93) as following: 
during exercise, heart rate increases as a result of sympathetic stimulation and parasympathetic 
withdrawal, to a lesser extent. Thus, increased venous return as a result of sympathetic 
vasoconstriction of the large capacity veins and also the pumping effect of muscular 
contraction generate an increase in stroke volume as the results of concomitant Frank-Starling 
effect. Also, an increase in systolic blood pressure can be seen with much greater cardiac 
output in spite of the decrease in peripheral resistance.  
Pharmacological stress: dobutamine  
Dobutamine is a catecholamine with a potent beta1-adrenoreceptor agonist activity and mild 
action on alpha1- and beta2-adrenoreceptors.(94) As a note, binding of a catecholamine to an 
adrenergic receptor or adrenoceptor stimulates the sympathetic nervous system. Hence, 
dobutamine induces a progressive increase in heart rate and myocardial contractility; therefore 
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produces an increase in the stroke volume and cardiac output as the results of both 
chronotropic (increase in heart rate) and inotropic (increase in EF) responses mediated by 
beta1-receptor.(93) A decrease in systemic vascular resistance mediated by beta2-receptor 
induces a mild increase in blood pressure.(95-97) Decline in central venous, pulmonary artery 
and capillary wedge pressures by dobutamine effect, in turn, results in a decrease in LV filling 
pressures and volume.(93) Also, myocardial oxygen demand will be increased in the response 
of the increase in both heart rate and contractility.(93) Beta2-mediated coronary vasodilation as 
a primary neural effect of sympathetic beta stimulation along with a beta1-mediated increase in 
heart rate, contractility and oxygen demand as a secondary metabolic effect of sympathetic 
beta stimulation, leads to an increase in coronary blood flow and increased perfusion in the 
regional myocardium.(98) It is the cause of using dobutamine stress test for diagnosing the 
CAD; since in the case of having an occlusion in one of the arteries, lack of regional blood 
flow can be seen in the myocardial image. High levels of dobutamine stress may induce 
ischemic wall motion abnormalities by increasing the myocardial oxygen demand in the case 
of any coronary stenosis. Whereas, low levels of dobutamine may improve the contractile 
response of the myocardial regions where show abnormal motion at rest, illustrating the 
contractile reserve.(99) 
 Dobutamine as an inotropic agent is also used as a treatment option in dilated 
cardiomyopathy patients with acute decompensated HF and low LVEF to improve the 
myocardial contractility and function until the acute causing problem is resolved or an ultimate 
therapy such as coronary revascularization or heart transplantation is performed.(51) Also, 
dobutamine has been used as a stress-induced agent in the assessment of MD either in CRT 
candidates for predicting the response to therapy(48) or in patients with dilated cardiomyopathy 
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without baseline electrical dyssynchrony for predicting the future outcomes.(50) The use of 
dobutamine in these circumstances helps to precisely identify the regional differences in the 
onset of myocardial contraction since stress-MD variations have been proven to correlate more 
with clinical outcomes.(48,50) 
Exercise versus dobutamine stress 
Comparing the treadmill exercise and dobutamine stress echocardiography, Rallidis et al.(93) 
demonstrated that the average heart rate as well as the systolic blood pressure thus workload in 
the exercise was greater than that obtained with peak dobutamine stress. Also, a greater 
ischemic burden was seen with exercise which was explained to be resulted from higher 
oxygen demand as an outcome of increased systolic blood pressure, heart rate, and myocardial 
contractility.(93) In another comparison study of the exercise and dobutamine stress 
echocardiography, Mehrotra et al.(100) reported that the degree of stress produced by 
dobutamine is considerably different than the exercise. In fact, exercise not only increases the 
cardiac myocardial contraction but also the skeletal muscle contraction that results in 
constriction of large capacitance veins and in consequence an increase in venous return. Since 
dobutamine does not increase the peripheral venous tone, it has been observed that  it produces 
greater reductions in LV EDV and ESV than exercise and along with lower systolic blood 
pressure, results in a lower wall tension and peak systolic stress.(100)   
 Owing to the hemodynamic differences between the exercise and pharmacological 
(dobutamine) stress and to be more realistic, it is recommended to use the exercise stress 
testing for examining the patients suspected to have a CAD.(100) There are several patient 
subsets in whom the exercise cannot be used or should be substituted with dobutamine or 
pharmacological stress such as the elderly patients (many of patients with HF), patients with 
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inadequate amount of exercise thus leading to inconclusive test results, and the patients in 
whom dynamic exercise might be absolutely (e.g. sever aortic stenosis or LV dysfunction) or  
relatively (e.g. tachyarrhythmias or bradyarrhythmias) contraindicated.(91) It is worth 
mentioning that patients undergoing dobutamine stress testing usually experience less angina, 
ST-segment depressions, and wall motion abnormalities relative to exercise stress testing.(100) 
Assessment of dynamic left ventricular dyssynchrony 
From 2005 to 2009, many types of research were performed to assess the feasibility of LV MD 
quantification under stress and also the MD variations and its relationship with other 
hemodynamic results and clinical outcomes.(46,48,101-104) Most of these studies reviewed by 
Lancellotti et al.(44) applied echocardiographic methods on patients with and without ischemic 
heart disease. The first precise study was performed by Lancellotti et al.(102) who showed a 
noticeable MD variation during exercise in patients with HF as a result of CAD. MD increased 
in about half of the patients (from 35 patients) and decreased or remained unchanged in others. 
A remarkable result in their study was the strong correlation between the exercise-induced 
variation in LV MD and the change in stroke volume, mitral regurgitation and brain natriuretic 
peptide release (a secreted hormone from ventricles during excessive stress that rises in several 
cardiac diseases(105)).  
 In a greater number of HF patients (n = 65) with QRS ≥ 120 in about 2/3 of patients, 
Lafitte et al.(46) demonstrated that HF patients showed either exercise induction or 
normalization of MD, of whom LV MD increased in 34% by at least 20%, remained stable in 
37%, and decreased in 29% by at least 20%. However, exercise did not modify the extent of 
dyssynchrony parameters in patients with normal LV function. Also, a significant correlation 
was found between exercise-induced changes in MD and the presence of ischemic 
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cardiomyopathy; since 80% of ischemic patients showed more than 20% of changes in MD 
during exercise as a result of abnormal regional wall motion. Lafitte et al. also confirmed the 
previous results based on the correlation between the stress-induced variation in LV MD and 
changes in cardiac output and mitral regurgitation. 
 In a different subset of patients, either with HF or normal ventricular function, 
researchers studied the effect of exercise or dobutamine stress on LV MD and confirmed the 
dynamic nature of dyssynchrony. In 60 patients with idiopathic dilated cardiomyopathy and 
narrow QRS, D’Andrea et al.(106) found that exercise unmasked the MD in more than half of 
the patients. Moreover, exercise-induced MD was independently associated with increased 
functional mitral regurgitation, reduced exercise capacity, and impairment of LV exercise 
stroke volume. Six years later in 2013, the same group reported the potential prognostic power 
of dynamic dyssynchrony in patients with dilated cardiomyopathy and narrow QRS.(50) In a 
cohort of 180 patients, they observed that the increase in echocardiographic dyssynchrony 
during exercise was the strongest predictor of cardiac events during a 4-year follow-up. Based 
on the results, they believe that assessment of LV MD during exercise can further improve the 
understanding of the pathophysiology of some functional and mechanical cardiac changes 
during the exercise, such as stroke volume impairment and an increase in mitral regurgitation 
severity.(50) Also, they emphasized on the use of stress-MD test besides the routine 
echocardiography not only for prognostication but also for better identification of patients who 
might benefit from CRT (if applicable as previously discussed). 
 Exercise dyssynchrony was also used by Rocchi et al.(48) to select the CRT responders. 
Sixty-four patients scheduled for CRT implantation performed exercise echocardiography 
before and 6 months after CRT implantation. Based on the results, exercise intra-ventricular 
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MD was a stronger predictor of CRT response than resting MD. Also, they noticed that 
exercise-induced a spatial change in the electromechanical activation of the LV, the lateral 
wall was the most delayed at rest but during exercise, the posterior wall became more delayed. 
Since more delayed site of activation is preferred to be stimulated during the CRT, the site of 
the LV lead might be better selected based on exercise rather than resting MD assessments.(48) 
Overall, dynamic dyssynchrony assessment is of special importance in CRT field based on 
many authors as they believe that neglecting the QRS duration at rest, HF patients who show 
significant dynamic dyssynchrony might benefit from CRT. In contrast, patients in whom 
ventricular MD disappears with exercise might not have a desire response to CRT.(48,50)  
 Using modern real-time 3-D echocardiography, Izumo et al.(107) studied the changes in 
LV shape and dyssynchrony during exercise and found a close relationship between the 
exercise dyssynchrony and the exercise-induced changes in LV shape and mitral regurgitation 
in HF patients. In fact, exercise-induced LV dyssynchrony and spherical remodeling resulted 
in mitral valve tethering and worsened mitral regurgitation in those patients.(107) 
 As previously mentioned, dobutamine can also be used as a stress agent instead of 
exercise for assessing dynamic LV MD. Using dobutamine infusion, Chattopadhyay et al.(101) 
showed that both the prevalence and severity of intra-ventricular LV MD increase in HF 
patients during stress no matter what the QRS duration is. Seventy-seven patients (47 with 
QRS ˂ 120 ms and 30 with QRS ≥ 120 ms) with HF due to LV systolic dysfunction and 22 
normal subjects underwent dobutamine stress echocardiography in this study. Although, 
dobutamine stress shortened the LV MD (time to peak systolic velocity in 12 segments) in 
healthy subjects, both the prevalence and severity of dyssynchrony increased in patients with 
systolic dysfunction irrespective of QRS duration.  The reason why the QRS does not matter at 
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peak pharmacological stress is that the prevalence of MD at rest is lower in patients with QRS 
˂ 120 ms; hence the stress-induced increase in MD was most visible in this population and 
approached that of patients with QRS ≥ 120 ms during dobutamine stress.(101) LV MD can also 
be unmasked and easily detected during low-dose dobutamine infusion in patients receiving 
CRT and its extent was shown to be related to the extent of reverse remodeling after CRT 
implantation.(45) 
 Feasibility of dynamic dyssynchrony quantification was evaluated by stress 
echocardiographic methods in most of the previous studies. However, during stress 
echocardiography, changes in heart rate, the type of stress-induced method, the absence of 
standard criteria by which to identify the dyssynchrony, and measurement errors due to procedural 
complications result in some intra- or inter-observational differences in identifying the 
dyssynchrony in HF patients. Phase analysis of nuclear imaging methods can solve the associated 
problems.    
Summary  
Both the proven importance of assessing stress MD in prediction of response to CRT and 
correlation with adverse outcomes, together with the appearance of more automated and 
reproducible techniques such as nuclear imaging have contributed to new clues for accurate 
MD assessment, while raising new questions: Which nuclear methodology is more accurate 
and robust in stress-MD assessments? What is the range of difference in inter- and 
intraventricular dyssynchrony parameters when the patient is submitted to various levels of 
functional stress? What is the range of difference in stress LV synchrony when different 
modes of electrical stimulation are applied? In another word, is the optimal pacing mode at 
rest, in terms of synchrony of contraction, also the best one during the exercise and increased 
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heart rates? The goal of current research is to answer these questions by providing three 
different experimental canine models and using the promising nuclear imaging techniques.  
Organization of thesis: objectives and approaches  
Under-stress ventricular mechanical dyssynchrony in this thesis is assessed by canine models 
in three different studies. In order to fully characterize the relation between cardiac stress and 
synchrony of contraction, multiple stress levels are required which is a long procedure and 
difficult to be performed on human subjects. In addition, invasive hemodynamic 
measurements are unbearable in a clinical subset. Therefore, experimental models are used to 
follow the procedures accurately and more flexibly in the current thesis.   
 
Chapter 1: The effects of dobutamine stress on cardiac mechanical synchrony 
determined by phase analysis of gated SPECT myocardial perfusion imaging in a canine 
model. 
Rational 
Stress-MD assessment is of special interest since it is a better predictor of response to CRT 
than QRS width or resting MD and its variations have been proven to correlate more with 
clinical outcomes. However, it is not known to what extent stress can modify the mechanics of 
the left ventricle. In addition, although the excellent repeatability and reproducibility of phase 
analysis of GMPS have been proven for LV MD measurements over echocardiography 
modalities, it is not well-known that which methodology in phase analysis is more accurate 
and robust in stress-MD assessments. Hence, a control study is needed to help better 
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understand the hemodynamic and mechanical characteristics of LV under various stress levels 
and to identify the best phase analysis methodology for stress-MD assessments.  
Hypotheses 
Dobutamine as a stress-induced factor modifies the synchrony of LV mechanical contraction 
and these synchrony variations can be shown more robustly through the thickening-based 
phase analysis than the displacement-based analysis.  
Specific objectives 
The primary objective of this study was to evaluate the effects of different levels of 
dobutamine on LV synchrony of contraction. The secondary objectives were to define 1) the 
feasibility and efficacy of our experiment protocol in this basic study, 2) the normal values of 
phase parameters either at rest or stress levels, and 3) the accuracy of two different methods of 
acquiring the phase dyssynchrony parameters (thickening or displacement) in GMPS imaging. 
The results of this study are discussed in detail in chapter 1 of the current thesis.  
 
Chapter 2: Phase analysis of gated blood pool SPECT for multiple stress testing 
assessments of ventricular mechanical dyssynchrony in a tachycardia-induced dilated 
cardiomyopathy canine model. 
Rational 
In the first study, we defined the mechanical characteristics of LV contraction under stress in 
the normal canine hearts. However, we were also interested in how dobutamine stress affects 
the mechanics of the ventricles in the presence of a systolic dysfunction. Few 
studies(46,50,101,108) have investigated the effect of stress on MD either in CRT candidates or in 
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patients with dilated cardiomyopathy and narrow QRS complex. However, none have 
examined the range of difference in inter- and intraventricular dyssynchrony parameters when 
the patients are submitted to various levels of stress. The quantification of stress dyssynchrony 
in those studies has been performed by different echocardiography-based methods. However, 
an intrinsic property of these methods lies in their limited reproducibility, since they are 
largely subject-dependent, both in the case of image acquisition and analysis.(55) Also, there is 
no standardized methodology with accurate and robust parameters for detecting mechanical 
dyssynchrony using echocardiographic imaging tools.(44) Hence, phase analysis of SPECT 
imaging specifically the GBPS can help to better understand the mechanical characteristics of 
LV contraction under stress both in the level of inter- and intraventricular dyssynchrony in an 
experimental model of non-ischemic cardiomyopathy and systolic dysfunction. 
Hypothesis 
Different levels of dobutamine stress even in close intervals can change the extent of inter- and 
intraventricular dyssynchrony in non-ischemic HF subjects.  
Specific objectives 
We aimed to examine the range of difference in inter- and intraventricular dyssynchrony 
parameters when the subjects were submitted to various levels of stress. The results of this study 
are discussed in chapter 2 of the thesis.  
 
Chapter 3: Effects of various modes of ventricular pacing on left ventricular mechanical 
synchrony under stress as assessed by phase analysis of gated myocardial perfusion 
SPECT in a canine model of atrioventricular block and normal function. 
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Rational 
After achieving the results of two previous studies with the focus of LV MD either in normal 
or in HF subjects, we attempted to further explore the relationship between the MD and pacing 
therapy. Until now, it is not well-known to what extent stress affects the synchrony of 
mechanical activation of a paced heart. During the period of stress, patients need to a more 
synchronous ventricular contraction and a better pumping function than the resting condition. 
Hence, whether the optimal pacing solution in terms of synchrony of contraction which is 
usually identified at rest can be the optimal one at stress condition is still a question. 
Considering the fact that previous evidence shows the superiority of stress-MD in predicting 
the response to CRT than resting-MD,(48) a detailed knowledge about mechanical 
characteristics of the pacing-induced LV contraction under stress condition is of special 
interest.  
Hypothesis 
BiV pacing with pre-activation of LV more resembles the intrinsic ventricular activation in 
developing normal contraction at stress. 
Specific objectives 
Our objective was to quantify the acute variations in LV function and MD during single, 
simultaneous, and sequential BiV pacing modes, under both rest and dobutamine stress levels 
in a canine model with normal function. The results are shown and discussed in chapter 3 of the 
current thesis. 
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Contribution statement 
The present thesis describes the author’s research accomplished at the Montreal Heart Institute 
(MHI) under the supervision of Dr. François Harel as part of the Ph.D. program at Université 
de Montréal. 
 The research was conducted with the collaboration of Dr. Bernard Thibault in the 
Electrophysiology Service of the MHI. The thesis author had no involvement in the study 
design, study protocol, and animal experimental procedures. Acquisitions were reconstructed 
following standard protocol by MHI technician, Sophie Marcil. Manual reorientation of the 
images, segmentations and functional and mechanical dyssynchrony (MD) assessments were 
performed by the thesis author. The current research used two different techniques for the 
assessment of MD: GBPS and GMPS. Besides using already available QGS software for the 
functional and MD assessments in GMPS, two other in-house MHI software packages, written 
by Vincent Finnerty the physicist, were used for the segmentation and data analysis in the 
current thesis for both aforementioned techniques. First, MHI segmentation software for 
GBPS which was formerly developed in 2007 for the volumetric analysis, then used for MD 
analysis in 2008, and validated in 2010 as an accurate measurement tool for volumetric 
analysis. It eventually was used during the current thesis for a complete assessment of 
functional and MD parameters with minor improvements in the case of MD analysis. Next, 
MHI4MPI segmentation software which was developed during this thesis used to assist in the 
diagnostic evaluation of under-stress ventricular MD in GMPS using the thickening- and 
displacement-based methodologies. Although the thesis author had no involvement in the 
software programming, she used these intuitively appealing software packages to analyze 
different aspects of under-stress ventricular contraction and when applicable, bring new idea 
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for further improvement in the case of analyzed parameters to better interpret the findings and 
to link the real-time hemodynamic outcomes with the MD results. The thesis author analyzed 
all the SPECT data referred to the current thesis from the segmentation to the subsequent 
phase analysis and ultimately the statistical data throughout all three subsets of animal studies.  
 Some of the findings of the current research were published as an abstract in Canadian 
Journal of Cardiology which was presented in Canadian Cardiovascular Congress and 
Canadian Association of Nuclear Medicine annual meeting and as journal articles in the 
Journal of Nuclear Cardiology which is outlined further in next section. 
 The thesis author prepared the manuscripts for publication and presented the abstract in 
oral and poster format in both conferences. Also, she responded to the reviewer’s comments 
for both the manuscripts which were published. Dr. François Harel, Dr. Bernard Thibault, Dr. 
Jean Grégoire, and Vincent Finnerty all helped to have intellectually vigorous discussions in 
the manuscripts and also all revised the manuscripts as well.  
 Except the software interfaces, all the thesis content including the literature reviews, 
tables and graphs were performed and produced by the author.  
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Abstract 
Background:  Precise identification of left ventricular (LV) systolic mechanical dyssynchrony 
may be useful in optimizing the response to cardiac resynchronization therapy in heart failure 
(HF) patients.  However, LV dyssynchrony is mostly measured at rest; patients often suffer 
from the HF symptoms during exercise.   
Objectives:  Our objective was to examine the impacts of stress on LV synchrony with phase 
analysis of gated SPECT myocardial perfusion imaging (GMPS) within a normal animal 
cohort.   
Methods:  Stress was induced with different levels of dobutamine infusion in 6 healthy canine 
subjects.  Hemodynamic properties were assessed by LV pressure measurements. Also, LV 
mechanical synchrony (coordination of LV septal and lateral wall at the time of contraction) 
was determined by phase analysis of GMPS using commercially available QGS software and 
in-house MHI4MPI software, with thickening- and displacement-based method.  Synchrony 
indexes in MHI4MPI included the septum-to-lateral delay and homogeneity index, derived 
from each of the two methods.  Also, bandwidth, SD and entropy (synchrony indexes) of the 
QGS software were assessed.   
Results:  LVEF increased from 36.7 ± 8.7% at rest to 53.67 ± 12.34% at 20 µg/kg/min 
(P<0.001).  Also, cardiac output increased from 3.67 ± 1.0 L/min at rest to 8.4 ± 2.6 L/min at 
10 µg/kg/min (P<0.001).  The same trend was observed for dP/dtmax which increased from 
1,247 ± 382.7 at rest to 5,062 ± 1800 mmHg/s at 10 µg/kg/min (P<0.01).  Entropy decreased 
from 55.2 ± 8% at baseline to 43.5 ± 8.5% at 5 and 43.0 ± 3.7% at 10 µg/kg/min dobutamine 
(P<0.01).  Thickening homogeneity index showed a difference from 91.7 ± 5.53% at rest to 
98.2 ± 0.75% at 20 µg/kg/min (P<0.05).   
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Conclusion:  Dobutamine stimulation could amplify the ventricular synchrony, and the 
thickening-based approach is more accurate than wall displacement for assessment of 
mechanical dyssynchrony in GMPS. (J Nucl Cardiol 2013) 
Keywords: Cardiac resynchronization therapy ▪ contraction homogeneity ▪ gated-SPECT 
myocardium perfusion imaging  
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Introduction 
Left ventricular (LV) mechanical dyssynchrony has become as an important clinical parameter 
for optimizing the response to cardiac resynchronization therapy (CRT) in heart failure (HF) 
patients.1  There are many lines of evidence that the magnitude of mechanical dyssynchrony 
would increase the CRT efficacy in HF patients.1-5  Most of the studies concerning the 
measurements on ventricular dyssynchrony have been accomplished at rest.  However, 
patients often suffer from the HF-related symptoms during exercise.  
 Echocardiography has extensively been used up to now for diagnosing the LV 
dyssynchrony.6-8  During exercise echocardiography, changes in heart rate, the type of stress-
induced method, the absence of standard criteria by which to identify the dyssynchrony and 
measurement errors because of procedural complications result in some intra- or inter-
observational differences in identifying the dyssynchrony in HF patients.9  
 Currently, assessment of cardiac dyssynchrony with phase analysis of gated single-
photon emission computed tomography (SPECT) myocardial perfusion imaging (GMPS)10 has 
provided valuable diagnostic information on LV function and volumes incorporated with the 
information about myocardium viability, ischemia, and prognostic information on cardiac 
dyssynchrony.11-13  Repeatability and reproducibility of phase analysis of GMPS have been 
shown to be excellent for measuring LV dyssynchrony.14  
 Previously, we developed and validated new segmentation software (MHI) for accurate 
and reproducible analysis of radionuclide-gated blood-pool SPECT (GBPS) imaging.  The 
accuracy of volumetric estimates, as well as LV ejection fraction was yielded in comparison 
with the planar isotopic ventriculography and cardiac magnetic resonance imaging as a gold 
standard for volumetric measurements.15  Moreover, we previously described and validated a 
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novel Contraction Homogeneity Index (CHI) as a single parameter for evaluating the 
ventricular dyssynchrony in 3D GBPS imaging.16  We improved the MHI software to analyze 
under-stress mechanical dyssynchrony in GMPS that, to our knowledge, there have been no 
reports concerning this issue.  
 Accordingly, the aim of this study was to evaluate the effects of different levels of 
dobutamine, as a stress-induced factor, on LV synchrony of contraction with phase analyses of 
GMPS using our in-house software (MHI4MPI) in comparison with already available QGS 
software, within a normal cohort. 
 
 
Methods 
General Preparation 
The protocol was approved by the local Animal Ethics Committee and all procedures followed 
the guidelines of the Canadian Council on Animal Care.  Six adult male dogs (mixed races; 
mean weight 36.73 ± 3 kg) underwent a general anesthesia with isoflurane 1.5% after 
induction with doses of 5 mg kg-1 ketamine/0.25 mg kg-1 diazepam.  Venous access and arterial 
access were initially obtained in carotid and femoral arteries as well as the jugular and femoral 
veins.  A Swan-Ganz catheter (931HF75, Edward Life Sciences, Mississauga, ON, Canada) 
was introduced in a segmental pulmonary artery in order to perform cardiac output 
measurements using the thermodilution method.  This method was followed by bolus 
injections of 10 ml of sterile physiological solution cooled to 4 ºC to increase the signal 
stability which was monitored using a standard biomedical recording device (Eagle 4000, 
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Marquette Medical System, Milwaukee, WI, US).  Surface ECGs were recorded using a 
standard three-lead configuration (Cardiac Trigger Monitor 3000, Ivy Biomedical Systems 
inc., Branford, CT, USA).  
 Additional peripheral venous access was positioned in the left leg for the dobutamine 
infusion.  A pressure catheter (Ventri-cath 507S, 5F, straight tip, Millar) was installed in the 
left ventricle via the left carotid artery.  Signals were conditioned (MPVS Ultra 753-2083, 
Millar), digitized (ITF156, Emka Technologies, Falls Church, VA, USA), and subsequently 
analyzed with a dedicated software (Iox2, ver. 2.5.1.6, Emka).  At the end of experiments, 
dogs were euthanized with the administration of isoflurane 5% and then using 149 mg kg-1 
potassium chloride which was injected into the dogs intravenously. 
 
Dobutamine GMPS Image Acquisition and Data Processing 
A standard gated SPECT myocardial perfusion scan with 99mTc-tetrofosmin (Myoview, GE 
Healthcare) protocol was performed using a dual-head gamma camera (e.cam; Siemens PA, 
USA), low-energy and high-resolution collimators, and 64 projections over a 360° arc with a 
64 × 64 matrix.  Myocardial perfusion gating was performed at 16 frames per R-R interval per 
projection. Immediately after the completion of baseline imaging with 99mTc-tetrofosmin (dose 
adjusted to dogs’ weight), dobutamine which was prepared in 500 μg/ml in saline solution was 
infused at different levels of 2.5, 5, 10 and 20 μg/kg/min over, in average, 31 minutes in 
continuous infusion at each level.  Standard gated image acquisition was acquired for each 
level, so that dobutamine increased to the expected level and stress image acquisition started 
without any rest period; that was the same over the entire experiments.  
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 Transaxial slices were generated by 2D-OSEM (10 iterations, 8 subsets) reconstruction 
and a Gaussian filtering of 8.4 mm with a reconstructed pixel size of 4.8 mm.  After manually 
reorienting images, cardiac gated short-axis images were produced with a provided camera 
software package (Siemens Autocardiac 8.5.10.1). 
 
Assessment of Phase Analysis in QGS 
Short-axis images were submitted to automatic segmentation QGS® 2009 software including 
the phase analysis plug-in (Cedars-Sinai Medical Center, Los Angeles, CA).  QGS phase 
analysis indicates the value of myocardial wall contraction synchrony using a phase 
distribution histogram and several parameters calculated for this distribution throughout a 
cardiac cycle17 such as phase histogram bandwidth (the width of the band with 95% of the 
samples over the entire LV), mean phase, SD (standard deviation) and entropy (a degree of 
variability in histogram phase angle).  In fact, in the assessment of cardiac synchrony, the 
number of phase angle measurements in the histogram would identify the entropy value.  If 
only one phase value exists in the histogram, entropy would be equal to zero and synchrony of 
contraction would be in the maximum level.17  In addition, LV functional volumes and 
ejection fractions were obtained from this software. 
 
Assessment of Phase Analysis in MHI4MPI 
MHI4MPI segmentation 
The MHI4MPI segmentation software is a fully automated algorithm which assists in the 
diagnostic evaluation of mechanical dyssynchrony in GMPS by segmentation of the LV and 
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computation of phase analysis of wall contractions.  The first step to performing the 
segmentation was identifying the basal plane with automatic tracking points throughout the 
systolic and diastolic frames in a cardiac cycle using intensity and gradient values.  Afterward, 
a deformable surface iterative algorithm (3D-Snake) was applied on the static mid-
myocardium surface, where external forces pushed towards maximal intensity in the image 
while internal forces kept the surface smooth.  
 The second step consists of creating endocardium and pericardium surfaces and 
applying a deformable dynamic surface algorithm (4D-Snake) in the gated images.  In each 
frame, the external forces would track along the normal of each surface to find the maximum 
intensity for the mid-myocardium and the zero crossing of the Laplacian for the endocardium 
and pericardium.  On top of the smoothing internal force, the three surfaces were kept close to 
one another and a unique basal ring was forced on all three surfaces.  Finally, to insure that the 
movements were smooth and continuous, temporal forces were used to remove high-frequency 
harmonics on each vertex; Figure 1-1. 
 Once the myocardium wall edges were constructed, phase analyses were performed 
with either the thickening or the displacement methods.  The always present partial volume 
effect leads to a greater decrease in maximum counts when the myocardium is thinner; Figure 
1-2.  Therefore, the intensification for each vertex on the maximal surface was used as a local 
thickening estimation for each frame.  The software averages relative intensification in septal 
and lateral wall; Figure 1-3.  Then, a three-harmonic Fourier analysis was used to estimate the 
phase (timing) and amplitude of the contraction, in both thickening and displacement methods; 
Figure 1-4.  Indeed, the phase, measured as an angle, is the base of all dyssynchrony 
parameters. Subsequently, cross-correlation of the septal and lateral mean thickening signals 
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was used to obtain the thickening-based septal-to-lateral wall delay (TSLD) as an index of 
intraventricular mechanical dyssynchrony.  In fact, the septum-to-lateral delay is frequently 
used in almost all modalities in order to predict the response to CRT.3,18,19  We adapted the 
CHI, as previously introduced in our group for GBPS,16 to quantify another thickening-based 
synchrony index.  CHI is a transformation of the ratio between wall motion contribution in 
stroke volume and total wall movement.  The thickening homogeneity index (THI), computed 
using the same equations, now represents the proportion of wall thickening that is in 
synchrony with the average thickening.  In fact, the average efficiency is the projection along 
the direction of the mean phase and is negative if the vertex phase differs from the mean phase 
for more than a quarter of the cardiac cycle.  THI, though, is measured by the average 
efficiency divided by average amplitude; Figure 1-4.   
Also, to estimate the myocardium displacement, principle component analysis was used 
to find the direction of the largest possible variance for each vertex of the mid-myocardium 
surface.  The motion was analyzed by projecting the 3D displacement along that vector with 
the positive direction defined as pointing outside of the mid-myocardium.  With these 
displacement signals, we computed a displacement-based septal-to-lateral wall delay (DSLD) 
and displacement homogeneity index (DHI).  Results were expressed with degree (°).  With 
the same sets of data from acquisition to reconstruction, the software itself would result in 
reproducible outcomes.  
 
Statistical Analysis 
Statistical analysis was performed using GraphPad Prism (version 6.0; GraphPad software, 
San Diego, CA).  The effects of dobutamine stress were investigated by repeated measures-
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one way analysis of variance (ANOVA) for each phase parameter to consider any significant 
differences between dobutamine levels.  Tukey’s multiple comparison post-tests were just 
implemented if the P value of ANOVA was significant. Continuous variables are presented as 
the mean ± SD.  A two-tailed P-value of < 0.05 was considered statistically significant. 
 
 
Results 
Baseline Assessments 
Cardiac hemodynamic and thermodilution characteristics of animals including in this study 
were recorded for 5 dogs due to inaccessibility of Millar software, while volumes, LV ejection 
fraction (LVEF), and all phase analyses were measured from all six animals.  The mean 
baseline heart rate and RR-interval during GMPS were 111.6 ± 19.0 bpm and 558 ± 87.9 ms, 
respectively.  The mean baseline cardiac output (CO) and LVEF were 3.7 ± 1.0 L/min and 
36.7 ± 8.7%, respectively; Table 1.  The value of LVEF in baseline measurements was not a 
normal expected value at rest for the normal samples, which might be due to the deep sedation 
of animals.  
 
Functional Effects in Response to Dobutamine Stress  
Hemodynamic and functional effects of dobutamine stress stimulation are shown in Table 1.  
The mean value for RR-interval was significantly decreased with the increase of the 
dobutamine level in a linear trend, which reflects the shortening of the cardiac cycle during the 
stress stimulation (P<0.01).  Dobutamine infusion resulted in a significant increase in LV 
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systolic performance.  CO increased from 3.7 ± 1.0 L/min at rest to 8.4 ± 2.6 L/min at 20 
µg/kg/min dobutamine level (P<0.0001).  The dP/dtmax indicated a significant systolic 
contractile state between baseline and 5 and 10 µg/kg/min dobutamine levels; Table 1, Figure 
1-5.  A significant increase in contractility index (CI) was measured only between baseline and 
5 µg/kg/min (P<0.05); Table 1, Figure 1-5.  CI was defined as the dP/dtmax divided by the 
pressure at this point.  It seems that there is a dose-response effect with a plateau at 10 ± 
5 µg/kg/min in almost all the hemodynamic parameters.  
 Also, LVEF showed a significant difference with an increase of the dobutamine from 
baseline to 20 µg/kg/min (P<0.001).  The same trend was measured for stroke volume (SV) 
(P<0.01).  There was a significant reduction in LV end-systolic volume (LVESV) at low dose 
dobutamine infusion (2.5, 5 µg/kg/min) with respect to the baseline; however, LV end-
diastolic volume (LVEDV) remained unchanged; Table 1.  
 
Phase analysis in QGS via Dobutamine Infusion 
Figure 1-6 illustrates the variation of phase parameters, acquired by QGS software, in response 
to the dobutamine infusion.  As it is been shown, all the dyssynchrony parameters demonstrate 
a falling trend with an increase of the dobutamine level, suggesting more synchronous 
mechanical activation during stress.  Baseline GMPS phase analysis made a mean histogram 
bandwidth of 93.0° ± 38.8° (range 36°-150°) and a mean phase SD of 25.7° ± 11.7° (range 
9.5°-44.4°).  There was a significant decrease in both histogram bandwidth and phase SD 
(45.0° ± 15.5° and 11.7° ± 4.6°, respectively; P<0.05) while increasing the dobutamine dose to 
20 µg/kg/min.  However, there was no apparent difference between baseline and other stress 
levels in both bandwidth and phase SD after post-tests.  Analysis of mean phase revealed that, 
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except for dobutamine level of 2.5 µg/kg/min, there is a significant difference between the 
baseline and other stress levels (110.1° ± 29.6° at baseline vs 77.1° ± 22.4° at 2.5, 68.1° ± 
21.5° at 5 and 54.5° ± 25.8° at 20 µg/kg/min; P<0.001).  Furthermore, entropy has changed 
significantly through the infusion between the baseline and dobutamine levels of 5 and 10 
µg/kg/min (55.2% ± 8% at baseline vs 43.5% ± 8.5% at 5 and 43.0% ± 3.7% at 10 µg/kg/min; 
P<0.01).  Reduction of entropy in these dobutamine levels may reflect more LV contraction 
synchrony.  The variations of all phase parameters in function of dobutamine stimulation 
mostly appear around the dose of 5 µg/kg/min dobutamine. 
 
Phase Analysis in MHI4MPI via Dobutamine Infusion  
The dyssynchrony parameters acquired by MHI4MPI, with the thickening vs displacement 
method, in the function of dobutamine level are shown in Figure 1-7.  Mean phase angles 
measured by the thickening method indicated a significant difference between baseline and 10 
and also 20 µg/kg/min dobutamine levels; Figure 1-7A (-78.0° ± 32.3° at baseline vs -108.0° ± 
21.7° at 10 and -122.7° ± 30.5° at 20 µg/kg/min; P<0.05).  In comparison, mean phase 
calculated by the displacement method did not reveal any significant difference between 
baseline and higher dobutamine levels (-89.7° ± 43.0° vs -129.5° ± 34.5° at 20 µg/kg/min; 
P>0.05).  As it has been shown in Figure 1-7B, TSLD and DSLD also did not indicate any 
significant difference with variation of dobutamine levels (-5.5° ± 22.5° at baseline vs -1.0° ± 
7.3° at 20 µg/kg/min, P>0.05; 25.3° ± 18.9° vs 45.17° ± 21.4°; P>0.05, respectively).  THI 
had a slight increase through increase of dobutamine level; Figure 1-7C, (91.7% ± 5.5% at 
baseline vs 98.2% ± 0.75% at 20 µg/kg/min; P=0.02).  In the case of DHI, no significant 
difference between the mean values of each level was seen (64.7% ± 20.3% at baseline versus 
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77.5% ± 14.9% at 20 µg/kg/min; P>0.05).  Moreover, there was an excellent correlation 
between the mean phase calculated by MHI4MPI and that of QGS software at each level of 
dobutamine; Pearson r > 0.9; Figure 1-8. 
 
 
Discussion 
This is the first under-stress analysis of LV mechanical dyssynchrony using phase analysis of 
gated SPECT MPI.  This study demonstrates the influence of dobutamine stress on LV 
mechanical dyssynchrony and its functional characteristics.  According to the entire results, 
the increase of dobutamine level is in accordance with improvement in LV functional capacity 
and reduction in dyssynchrony parameters.  In fact, the considerable enhancement in cardiac 
functional capacity due to dobutamine infusion is because of improvement in ventricular 
synchrony.  The evidence for this claim is a significant increase of LVEF, CO, dP/dtmax along 
with improvement in THI, and also drop-off entropy value (27.8%) with dobutamine infusion.  
It seems that most of the variations in parameters (Figures 1-5, 1-6) happened at low dose (5, 
10 µg/kg/min) dobutamine levels and there are dose-response effects with a plateau at 10 ± 5 
µg/kg/min in almost all parameters. 
 Cardiac dyssynchrony analysis based on wall thickening seems to be more robust and 
sensitive than the global wall displacement. In fact, average TSLD at baseline was close to 
zero (-5.5°, 1.8°, -0.1°, -1.3°, -1° for 0, 2.5, 5, 10 and 20 µg/kg/min of dobutamine 
respectively).  In contrast, the average measurements for DSLD were completely positive 
(25.3°, 21.8°, 27.8°, 31°, and  45.1° for 0, 2.5, 5, 10, 20 µg/kg/min of dobutamine, 
respectively).  Although, the positive values did not reveal a significant difference, indicated a 
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later contraction in the lateral wall than in the septal wall, which is more likely to happen in 
patients with left bundle branch block (LBBB)17, not in our cohort.  The same observation was 
seen for baseline DHI indicating a low magnitude for a normal cohort, which is not plausible.  
In contrast, baseline THI was around 90% and there was a slight improvement with response 
to the dobutamine stress level.  Also, thickening-based mean phase in MHI4MPI showed an 
excellent correlation with that of QGS software for LV dyssynchrony analysis in each 
dobutamine level.  
 The preference of the thickening method was also observed by other groups in 
perfusion and functional assessments of coronary artery bypass surgery patients using gated 
SPECT.20,21  In the presence of normal septal thickening, wall motion analysis was shown as 
an underestimation of septal and overestimation of lateral motions which appear typically in 
post-cardiac surgery patients.  The authors recommended the thickening as it is more accurate 
for evaluation of pseudo-paradoxical motion in these patients.  Van Kriekinge et al. 
investigated the global and regional phase analysis of GMPS in normal and LBBB patients 
with QGS software.17  They found an average timing difference around zero for both global 
and regional septal and lateral wall contractions in normal patients (-1.1° and -1.7° for wall- 
and segmental-based calculations, respectively).  Their results are comparable with ours for 
TSLD which is close to zero. 
 The effects of different kinds of stress-induced factors on ventricular dyssynchrony 
have had contradictory results.  Some studies have mentioned that mechanical dyssynchrony 
did not change during cardiac stimulation using stressors like exercise or pharmacological 
agonists.22-24  Lafitte et al. assessed the effects of exercise on ventricular dyssynchrony in 
patients with normal and depressed LV function.22  They mentioned that dyssynchrony 
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parameters did not significantly differ between rest and exercise in normal subjects.  However, 
exercise could modify the extent of dyssynchrony parameters (20%-26%) as reflected by its 
shortening or reverse.  However, Chattopadhyay et al. studied the effects of dobutamine on 
intraventricular dyssynchrony in patients with LV systolic dysfunction vs control subjects.25  
They found that dobutamine shortened the intraventricular delay in all the segments of LV in 
healthy subjects on stress echocardiography.  A comparison with our results remains difficult 
due to major differences in methodology used.  Kasama et al. demonstrated that dobutamine in 
99mTc gated SPECT could predict improvement of cardiac function in patients with dilated 
cardiomyopathy.26  The authors mentioned that the exact mechanism responsible for the 
improvement in systolic function during dobutamine infusion is unclear.  However, as 
mentioned before, in our point of view, a desirable cardiac performance during the 
administration of dobutamine stress is due to the improvement in ventricular synchrony. 
 As a matter of fact, the value of LVEF at baseline measurements in our study was not a 
normal expected value at rest for the normal samples.  Several reasons could result in 
acquiring underestimated LVEF in the present study.  The precision of LVEF measurements 
for animals is unknown in QGS software.  Also, the software cannot rely on the accuracy of 
count-based LVEF in myocardial perfusion imaging.  However, it might be the result of the 
deep sedation of the animals through the entire experiments.  Even so, improvement in EF 
after dobutamine stress injection was definitely apparent.   
 The results of phase analyses have been expressed using degree (°) instead of 
millisecond in this study as we believe that using the absolute value of a parameter for 
describing a cyclic mechanical behavior is not accurate specifically to compare normal ranges 
between species or for comparing results from the same subject with significantly different 
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HRs (rest vs stress).  Also, the use of degrees should give heart rate independent accuracy; 
since the acquisition is adjusted automatically to have exactly 16 time measurements every 
360°.  Moreover, the sign of the delay gives the ability to define which wall (septum or lateral) 
contracts first.  
 Above all, we found that inter-animal variation of phase parameters decreased with the 
increase of dobutamine concentration.  Although this kind of variability seems to be normal at 
baseline due to the individual mechanical and electrical characteristics,27,28 dobutamine is able 
to eliminate it by synchronizing the septum and lateral wall at the time of contraction.  In 
general, the results of this study confirm that the levels of cardiac activity could change the 
cardiac contraction synchrony and take these changes into account would be essential in the 
CRT optimization process, in particular, in the stress condition.  
 
Limitations  
There are several limitations in our study.  One of the major limitations is that the number of 
animals was limited in this study as it is always a restriction in animal experiments.  
Therefore, MHI4MPI requires more validation due to this problem.  In addition, Laplacian 
edge detection does not permit the exact measurement of wall thickness in the cardiac 
structure.  However, it could help us correctly position a coherent mid-myocardial wall.  Also, 
GMPS is not ideal for acquiring the accurate volume and LVEF.  Phase analysis measurement 
in high dobutamine levels was difficult since ventricles had completely collapsed.  Moreover, 
the gating process in HF patients with irregular heart rhythm (e.g., atrial fibrillation) would be 
complicated and it is hard to get good image quality of the average heart beat in these patients.  
Besides the normal cohorts, further analysis within the HF animal model is needed to compare 
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the dyssynchrony results, which is already on hand.  Finally, analysis of dyssynchrony 
parameters before and after resynchronization therapy would be interesting to see the 
efficiency of predictors on CRT response.  
 
 
New knowledge gained 
The increase of dobutamine level is in accordance with the improvement of LV functional 
capacity and reduction of dyssynchrony parameters. Cardiac dyssynchrony analysis based on 
wall thickening seems to be more robust and sensitive than the global wall displacement. 
 
 
Conclusion 
As phase analyses of GMPS indicated, dobutamine significantly increases the LV synchrony 
of contraction in normal cohorts.  The proposed MHI4MPI software with useful indexes using 
the thickening- and displacement-based methodologies could indicate the mechanical 
synchrony alterations.  Evaluation of thickening- and displacement-based results demonstrates 
the reliability and sensitivity of thickening-based over the displacement-based method for 
identifying the mechanical dyssynchrony.   
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Tables 
 
Table 1-1: LV functional parameters during rest and levels of dobutamine stress 
Index 
Dobutamine (µg/kg/min) 
0 2.5 5 10 20 
LVEDV (mL) 54.7±11.5 47.8±9.8 48.7±9.4 49.7±9.6 53.0±8.3 
LVESV (mL) 34.8±9.7 24.3±6.7* 24.0±5.3* 25.2±5.6 24.2±5.8 
LVEF (%) 36.7±8.7 49.0±10.5* 50.8±9.3* 49.0±10.9* 53.7±12.3* 
SV (mL) 19.8±5.3 23.5±7.7 24.7±7.5 24.5±8.7 28.8±9.1* 
HR (bpm) 111.6±19.1 152.4±51.9 232.6±88.6 248.4±149.6 254.0±153.6 
QRS width (ms) 43.8±3.7 46.4±4.7 47.8±3.7 47.2±6.3 47.0±6.0 
R-R (ms) 558.0±87.2 452.2±78.4 380.6±90.3* 347.0±127.9* 335.6±136.8 * 
Pmax (mmHg) 74.4±8.8 104.3±16.1* 113.8±12.3* 131.7±18.7* 161.2±45.2* 
dP/dtmax (mmHg/s) 1247±382 3075±1340 3875±1342*# 5062±1800*# 6155±2465 
CI (s-1) 46.9±25.0 62.5±34.2 67.2±29.8* 76.8±24.5 86.9±27.4 
CO (L/min) 3.7±1.0 5.4±1.9 6.6±2.2* 7.5±2.0*#ǂ 8.4±2.6*#ǂ 
n=5 for all except LVEDV, LVESV, SV and LVEF (n=6).  Data are presented as mean ± SD. 
*=P ≤ 0.05 vs baseline; #=P ≤ 0.05 vs 2.5; ǂ=P ≤ 0.05 vs 5 µg/kg/min (RM ANOVA, Tukey's).  
LVEDV, left ventricular end-diastolic volume; LVESV, left ventricular end-systolic volume; 
LVEF, left ventricular ejection fraction; SV, stroke volume; HR, heart rate, R-R, time between 
R-R interval; Pmax, maximum pressure of left ventricle; dP/dtmax, maximum rate of left 
ventricular pressure change; CI, contractility index; CO, cardiac output.  
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Abstract 
Background:  Stress-induced dyssynchrony has been shown to be independently correlated with 
clinical outcomes in patients with dilated cardiomyopathy (DCM) and narrow QRS complexes.  
However, the extent to which stress levels affect inter- and intraventricular dyssynchrony 
parameters remains unknown.  
Methods:  Ten large dogs were submitted to tachycardia-induced DCM by pacing the right 
ventricular apex for 3-4 weeks to reach a target ejection fraction (EF) of 35% or less.  Stress was 
then induced in DCM dogs by administering intravenous dobutamine up to a maximum of 
20 μg/kg/min.  Hemodynamic and ventricular dyssynchrony data were analyzed by left 
ventricular (LV) pressure measurements and gated-blood pool SPECT (GBPS) imaging.  In order 
to assess mechanical dyssynchrony in DCM subjects and compare it with that of 8 normal 
counterparts, we extracted the following data: count-based indices of LV contraction 
homogeneity index (CHI), entropy and phase standard deviation (SD), and interventricular 
dyssynchrony index.  
Results:  A significant LV intraventricular dyssynchrony (CHI: 96.4% ± 1.3% in control vs 
78.6% ± 10.9% in DCM subjects) resulted in an intense LV dysfunction in DCM subjects (EF: 
49.5% ± 8.4% in control vs 22.6% ± 6.0% in DCM), compared to control subjects.  However, 
interventricular dyssynchrony did not vary significantly between the two groups.  Under stress, 
DCM subjects showed a significant improvement in ventricular functional parameters at each 
level (EF: 22.6% ± 6.0% at rest vs 48.1% ± 5.8% at maximum stress).  All intraventricular 
dyssynchrony indices showed a significant increase in the magnitude of synchrony from baseline 
to stress levels of greater than or equal to 5 μg/kg/min dobutamine.  There were individual 
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differences in the magnitude and pattern of change in interventricular dyssynchrony during the 
various levels of stress.  
Conclusions:  Based on GBPS analyses, different levels of functional stress, even in close 
intervals, can have a significant impact on hemodynamic and intraventricular dyssynchrony 
parameters in a DCM model with narrow QRS complex.  (J Nucl Cardiol 2015) 
 
Keywords: Ventricular dyssynchrony . gated blood pool SPECT . dobutamine stress . dilated 
cardiomyopathy with narrow QRS.  
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Introduction 
Ventricular mechanical dyssynchrony, defined as a timing disparity in ventricular regional 
contraction, seems to be present in almost all chronic heart failure (HF) patients.1  Wall motion 
discoordination is not exclusively caused by electrical conduction delays; regional heterogeneity 
in myocardial contractility properties can also modify the synchronicity of contraction.1, 2  The 
presence of mechanical dyssynchrony with preserved electrical conduction is apparent in a 
substantial proportion of patients with dilated cardiomyopathy (DCM) and narrow QRS 
complexes.3 
Exercise-induced intraventricular dyssynchrony has been independently correlated with 
clinical outcomes (combined endpoint of death, heart transplant, or assist device implantation) in 
patients with idiopathic DCM and narrow QRS complexes.4  However, few studies4-7 have 
investigated the effect of stress on mechanical dyssynchrony in such patients and none have 
examined the range of difference in inter- and intraventricular dyssynchrony parameters when the 
patients are submitted to various levels of stress.  Moreover, the quantification of stress 
dyssynchrony in those studies has been performed by different echocardiography-based methods.  
However, an intrinsic property of these methods lies in their limited reproducibility, since they 
are largely subject-dependent, both in the case of image acquisition and analysis.8  Also, there is 
no standardized methodology with accurate and robust parameters for detecting mechanical 
dyssynchrony using echocardiographic imaging tools.9 
In comparison with echocardiographic methods, phase analysis of nuclear cardiology 
modalities such as gated single-photon emission computed tomography (SPECT) myocardial 
perfusion imaging (GMPS)10 and gated blood-pool SPECT (GBPS)11 have shown a high 
reproducibility to effectively assess cardiac mechanical dyssynchrony.  While both methods have 
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shown a clear applicability in this field, GBPS has been preferred in some cases since it is based 
on volume rather than myocardial wall thickness. In addition, it can provide both inter- and 
intraventricular dyssynchrony data.  
Consequently, we used GBPS in our study to investigate the effects of various levels of 
dobutamine-induced stress on inter- and intraventricular dyssynchrony parameters in an animal 
model of tachycardia-induced DCM, a well-characterized model of non-ischemic 
cardiomyopathy in terms of left ventricular (LV) dilation and systolic dysfunction.12 This study 
follows our previous work performed on a control cohort.13   
 
 
Methods 
Study Protocol 
Ten large dogs of either gender (mixed races with mean weight of 40.2±4.5kg) were submitted to 
tachycardia-induced HF by pacing the right ventricular apex at 240 bpm for 3-4 weeks until the 
LV ejection fraction (EF) fell below 35%; we selected a moderate to severely reduced EF to 
assess variations toward upper or lower EF categories.  Experiments were initiated within 48hr of 
achieving the target LVEF.  The protocol was approved by the institutional Research Ethics 
Board and all procedures followed the Canadian Council on Animal Care. 
The animals underwent general anesthesia with isoflurane 1.5% after induction with doses 
of 5 mg/kg ketamine and 0.25 mg/kg diazepam.  SaO2 was monitored using a standard 
biomedical cardiac monitor (Eagle 4000, Marquette Medical System, Milwaukee, WI, USA).  
The dogs’ bladders were catheterized in order to prevent radioactive urine spills.  Venous and 
arterial accesses were obtained in carotid and femoral arteries as well as jugular and femoral 
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veins.  Those vascular accesses were used to install the following devices.  First, a Swan-Ganz 
catheter (931HF75, Edward Life Sciences, Mississauga, ON, Canada) was introduced in a 
segmental pulmonary artery to measure the cardiac output using a thermodilution method.14  This 
was followed by bolus injections of 10 mL of sterile saline cooled at 4°C to increase the signal 
stability. We used the cardiac monitor to measure cardiac outputs.  Second, a pressure catheter 
was introduced into the right femoral artery in order to acquire systemic arterial pressure signals.  
Signals were conditioned by a dedicated control unit and acquired by a signal acquisition system.  
Dobutamine was infused using the venous access in the left leg.  Another pressure catheter 
(Ventricath 507S, 5F, straight tip, Millar, Houston, TX, USA) was installed in the LV via the left 
carotid artery access.  Signals were conditioned (MPVS Ultra 753-2083, Millar), digitized 
(ITF156, Emka Technologies, Falls Church, VA, USA), and subsequently analyzed with a 
dedicated software (Iox2, ver. 2.5.1.6, Emka).  It has to be mentioned that hemodynamic results 
were recorded for eight dogs out of ten because the Millar system was unavailable.  Surface 
ECGs were recorded using a standard 3-lead configuration (Cardiac Trigger Monitor 3000, Ivy 
Biomedical Systems Inc., Branford, CT, USA). 
The GBPS and surface ECGs were acquired at baseline and for each dobutamine-induced 
stress level of 2.5, 5, 10 and 20 μg/kg/min.  The acquisition of GBPS was performed after red 
blood cell labeling using the UltraTag®-99mTc kit.  A single dose of radiopharmaceutical of 1223 
MBq in average was injected to animals and baseline images were acquired.  Cardiac stress was 
induced by a dobutamine infusion prepared in 500 μg/mL of normal saline solution and 
continuously infused over average times of 43.5, 28.4, 36.4 and 34.8 min while increasing the 
outflow to reach the predetermined dosage (Figure 2-1). Because of dobutamine’s short half-life 
of approximately 2.3 min, we used the continuous infusion to create a stable dobutamine stress 
effect for acquiring the SPECT images.  On average, the total infusion duration was 143.0 min, 
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during which a total volume of 415 mL was infused.  Immediately after reaching a target 
dobutamine concentration level, image acquisition was initiated. There were no rest periods 
during the entire experiment.  Cardiac and peripheral hemodynamic data, as well as cardiac 
contraction synchrony data (using GBPS) were recorded at each stress level.  The duration of 
GBPS acquisition was adjusted throughout the day to reach equal count statistics in spite of 99mTc 
decay time; average times of 10.8, 13.4, 14.3 and 14.8 min, respectively, were used for each 
dobutamine-induced stress level.  Overall, the dobutamine-induced stress effect lasted 
approximately 208.1 min, with the heart rate continuously increasing at each level.  Because of 
humane considerations, we euthanized the dogs at the end of the experiment with the 
administration of isoflurane 5% and an intravenous overdose of potassium chloride.  
 
GBPS Acquisition and Reconstruction 
Data were acquired on a dual head gamma camera with low-energy high-resolution collimators 
and 64 projections dispatched on a 360˚ configuration using 64×64 matrix.  Data acquisition 
involved 16 frames per cardiac cycle.  Transaxial reconstructions were performed with the ramp 
filtered back projection and subsequently filtered by 8mm Gaussian filter. 
 
GBPS Data Processing and Dyssynchrony Analysis 
Images were manually reoriented into LV short axis sections (Figure 2-2).  Segmentation was 
performed using an algorithm based on the invariance of the Laplacian previously developed by 
our group to deliver a dynamic surface of approximately 400 vertices.15  In summary, simple 
geometric assumptions were made to separate LV from RV and atria.  Two smoothed isosurfaces 
(LV and RV) were then determined inside both ventricular regions (LV left of the RV, both 
 90 
below the atria).  The GBPS images were filtered with a variable cutoff frequency, and Laplacian 
was computed for each data set.  Profiles were extracted from each Laplacian image by sampling 
along 400 vectors perpendicular to each of the ventricular isosurfaces (LV and RV).  These 
profiles were used to find a pivotal point, where values were the least variable between filtered 
data sets.  Since this position was resolution-independent, it represented a true edge estimation.  
This surface was then replaced by 3D self-organizing maps (LV and RV) using standard surfaces 
to get regular sampling over the ventricles. Again 400 profiles normal to these surfaces were 
analyzed to determine the invariance of the Laplacian for each bin of all 16 temporal bins (Figure 
2-3).  Lastly, post-processing was executed on the surfaces to ensure spatial and temporal 
continuity.  After the segmentation, dynamic regions of interest (ROIs) were estimated over both 
ventricles.  The LV ROI was defined as the pixels totally or partially inside the LV plus all pixels 
under the valvular plane and within 8mm (2 pixels) of the LV, but all pixels closer to the RV than 
the LV were excluded (Figure 2-4).  The same approach was applied to define the RV ROI.  
Time-activity curves (TACs) for the LV and RV were generated using these ROIs (Figure 2-4).  
Count-based LVEF and RVEF were measured directly using the TACs.  However, in order to 
measure the stroke volume (SV) in mL, we had to estimate count-based volumes by adjusting the 
TACs (dividing by the average TAC and multiplying by the average geometric volume, a method 
previously shown to be well correlated with magnetic resonance imaging volumetric results16).   
 A three-harmonic inter-correlation of the RV and LV TACs was used to compute the phase 
differences between RV and LV (count-based RVLV delay).  These results were expressed in 
degrees and converted to milliseconds to accommodate readers from different specialties 
(echocardiography, electrocardiography, etc.).  It has to be noted that any comparison between 
RVLV delays measured by GBPS and with other modalities will not be accurate since the 
methods for acquiring RVLV delays using various modalities are totally different.  
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 In addition, we extracted TACs for different regions of the LV from the LV ROI. First, the 
basal slices (where the surface’s normal angle to basal direction was less than 45°) were 
discarded.  Then, apical slices were extracted to evaluate the apical TAC separately.  The pixels 
from remaining median slices were split into four regions (anterior, lateral, inferior and septal) 
using their angular position in the short axis slice around the LV center (Figure 2-5).  We first 
estimated Fourier harmonics of each regional TAC to obtain the phase and amplitude of each LV 
region.  In order to compute the LV intraventricular dyssynchrony parameters, a static ROI was 
used containing the voxels where the LV dynamic ROI was present at least in half of the 
temporal frames.  Three-harmonics Fourier analysis of all voxel TACs and subsequent 
count-based amplitudes (A) and phases (θ ) were acquired within this ROI.  In addition to the 
phase and amplitude, efficiency (E) of contraction of each voxel was also determined, namely, 
the portion of amplitude in phase with the remainder of the ventricle.17  In other words, E 
represents the portion of amplitude in the direction of the mean phase.  Thus, E could be 
calculated as complex harmonic of each voxel TAC ( iAe θ ) divided by the mean phase (θ ), 
which is the mean angle of all complex harmonics, as following:  
1
1
i
i
A eE
e
θ
θ=  iAe θθ = ∠  (2-1) 
Based on the above equation, E is actually the projection along the direction of the mean 
phase in the Fourier space.  It would be negative if the voxel phase differed from the mean phase 
for more than a quarter of the cardiac cycle.  In fact, the E index was used to calculate a global 
contraction homogeneity index (CHI)17 which was defined as the mean E divided by the mean A.  
In our point of view, CHI could be interpreted as the proportion of wall movement (endocardial-
blood interface movement) that contributes to the stroke volume.  
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In addition to CHI, phase standard deviation (phase SD) and entropy of the phase histogram 
were extracted within the LV static ROI.  These dyssynchrony parameters have been previously 
evaluated in planar and radionuclide ventriculography phase analysis.11, 18, 19  Entropy is a degree 
of randomness of the phase distribution within the ROI.  In the case of reduced contraction 
homogeneity, entropy is able to identify the degree of random and uncoordinated contraction by 
computing the probability of occurrence of phase angle i  ( iP ) in a given number of bins ( M ) of 
a phase histogram as following:  
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We used the same equation and method proposed by O’Connell et al. to measure the entropy 
values.18  It ranges from 0 with complete order and 1 with complete disorder. 
 
Statistical Analysis 
Statistical analysis was performed using GraphPad Prism version 6.00 for Windows (GraphPad 
Software, La Jolla, California, USA).  The D'Agostino-Pearson test was used to confirm that the 
distribution of the hemodynamic. as well as dyssynchrony variables were not significantly 
different from a normal distribution at different dobutamine levels. 
Comparisons between rest and dobutamine-induced stress levels for functional and dyssynchrony 
parameters were made using ANOVA test for repeated measures with Tukey post-test.  Also, 
comparisons between control and DCM groups were made using the unpaired Student t test.  In 
addition, a correlation test was used to assess the relation between various cardiac output 
measurements.  Statistical significance was defined as a two-tailed P-value <0.05.  Data are 
shown as mean values ± SD for the continuous variables. 
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Results 
Effects of Stress on Functional Parameters 
Functional parameters at rest and during levels of dobutamine-induced stress in DCM dogs are 
shown in Table 1.  D'Agostino-Pearson test confirmed that the distribution of the hemodynamic 
variables was not significantly different from a normal distribution (P > 0.1).  The progressive 
dobutamine infusion resulted in a marked increase in heart rate, from 107.1 ± 10.5 bpm at rest to 
134.7 ± 12.2 bpm for the maximum level of pharmacological stress.  Immediately after the initial 
pharmacological stimulation with a small amount of dobutamine, a significant increase in LVEF 
(22.6% ± 6.0% in baseline vs 29.5% ± 7.5% in 2.5 μg/kg/min; P < 0.02) was observed.  Further 
significant differences were shown at higher levels (P < 0.0001).  Interestingly, the same results 
were seen in RVEF (P < 0.0001).  Also, a significant increasing trend was observed in the cardiac 
output by both radionuclide and thermodilution methods with the increase of dobutamine doses 
(P < 0.0001), and methods indicated a good correlation in cardiac output measurements 
(Pearson’s correlations at each dobutamine level > 0.7).  Modulations of LV end-systolic and 
diastolic volumes (ESV, EDV) with increasing doses of dobutamine enhanced the stroke volume.  
Although the LV end-diastolic pressure (EDP) was still preserved in response to doses of 
dobutamine, volume alterations produced a constant progression in the maximum rate of rise of 
LV pressure (dP/dtmax; 949.5 ± 238.5 mmHg/s at baseline vs 3,020.8 ± 568.9 mmHg/s at 
20 μg/kg/min; P < 0.0001).  QRS duration was almost constant and did not change significantly 
with the varying stress levels.  
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Effects of Stress on Intraventricular Dyssynchrony 
Dyssynchrony parameters at rest and during dobutamine-induced stress levels in DCM vs control 
dogs are shown in Table 2.  The D'Agostino-Pearson test confirmed that the distribution of the 
dyssynchrony variables did not significantly differ from a normal distribution (P >0.2).  All 
subjects revealed a significant amount of LV dyssynchrony at rest.  However, dobutamine 
significantly increased the synchrony of contraction in all subjects.  Figure 2-6 (A-C) shows the 
count-based LV contraction phase of a control vs DCM dog at baseline and at maximum stress 
level.  As has been shown, LV regions in a DCM subject contract according to different phases 
and amplitudes.  Although these uncoordinated contractions are substantially normalized at 
maximum stress level, they still show some differences when compared to the normal pattern.  In 
the control group, a plateau was observed at the dobutamine level of 5 μg/kg/min for CHI and 
entropy values, meaning that 5 μg/kg/min dobutamine was an appropriate amount to generate 
maximum contraction efficiency in those subjects.  In comparison, CHI showed a significant 
improvement from baseline to stress levels of 5 μg/kg/min dobutamine or greater (P < 0.05) in 
DCM subjects.  Similar results were found for entropy and phase SD.  Septal displacement was 
significantly out of phase with the LV (later than the lateral wall at rest).  However, it was 
normalized at peak dobutamine stress; this contrasts with the apex, which showed a significant 
difference relative to the LV phase and remained out of phase even at maximum stress (P < 
0.002, Figure 2-7).  An example of one DCM dog with reduced apex and septum contraction 
efficiency is shown in Figure 2-8. 
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Effects of Stress on Interventricular Dyssynchrony 
Interventricular dyssynchrony was negative in all except one DCM subject at rest.  A delay is 
defined as negative when the LV contracts earlier than the RV (Figure 2-9).  Although a visual 
trend toward improvement of RVLV synchrony (approaching to zero) was observed with 2.5 
µg/kg/min dobutamine, overall no significant change was seen between rest and the maximum 
stress level in this parameter, even when considering absolute values (-20.9 º ± 21.1º (-33 ± 33.4 
ms) at baseline vs -22.2 º ± 11.5º (-27.6 ± 14.6 ms) at 20μg/kg/min, P < 0.25; 25.0º ± 15.4º at 
baseline vs 22.2º ± 11.5º at 20μg/kg/min, in absolute values, P < 0.08; Table 2).  In fact, as has 
been shown in Figure 2-9, there were individual differences in the magnitude and pattern of 
change in interventricular dyssynchrony during the various levels of dobutamine stress and it was 
hard to draw a certain direction of change in RVLV delay measurements.  
 
Control versus DCM Group 
Comparison of LV dyssynchrony and functional parameters between the DCM and control dogs 
at rest and at maximum stress level is shown in Table 3.  In general, DCM dogs showed a 
depressed ventricular function (EF, dP/dtmax).  Also, all intraventricular dyssynchrony indices in 
this cohort showed significant differences in comparison to the control subjects both at rest and 
under maximum stress levels (all lower than normal values).  In the DCM cohort, septal 
contraction always occurred later than LV lateral wall contraction.  The introduction of cardiac 
stress did not change the pattern of mechanical contraction in the DCM cohort, which was always 
a lateral-to-septal (Figure 2-7), compared to LV contraction in the control group, where 
dobutamine-induced stress resulted in a septal-to-lateral pattern.  There was no significant 
difference between the DCM and control subjects in interventricular mechanical dyssynchrony at 
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rest (P < 0.08) and notably at maximum dobutamine stress (P < 0.91).  In average, LV 
contraction preceded RV contraction in both groups at rest.  Due to the increase in ventricular 
conduction speed, a progressive early LV contraction was apparent in subjects with normal 
cardiac contraction under dobutamine-induced stress.  However, the interventricular synchrony 
was not hampered during the stress condition in these subjects.  In comparison, individual 
differences in the magnitude and pattern of change in interventricular dyssynchrony precluded 
the existence of a statistically significant trend of change in this parameter during the various 
stages of dobutamine stress in the DCM cohort.  
 
 
Discussion 
The range of difference in ventricular dyssynchrony parameters between rest and levels of stress 
has rarely been studied in cardiac failure subjects.  The current study performed by GBPS 
showed that, even in close intervals, different levels of dobutamine stress could have a significant 
impact on ventricular function and intraventricular dyssynchrony parameters in DCM subjects 
with narrow QRS complexes.  
 
GBPS for Assessing Stress Dyssynchrony  
In echocardiography, a few points in space and a few heartbeats are used to estimate either 
maximum temporal delay or standard deviation of delays over the entire LV segments. In 
contrast, GBPS uses several hundred data points in space and multiple data points in time that are 
taken from the analysis of a complete cardiac cycle which has been averaged over hundreds of 
cardiac cycles at the time of acquisition.  Cross-correlation of the mean phase of all points, either 
 97 
regionally or globally, thus results in the direct measurement of mechanical dyssynchrony.  
GBPS is fully automated (in our case more than 90%) and provides highly reproducible 
dyssynchrony indices.10  In comparison, several different and complicated segmental analyses in 
echocardiography result in substantial errors and high inter- and intraobserver variability.8  
Currently, GMPS plays a central role in the visual and quantitative characterization of LV 
dyssynchrony.  However, it cannot replace GBPS, since GBPS can provide both inter- and 
intraventricular dyssynchrony data, especially in the presence of perfusion defects.  Recently, 
GBPS has also been used to gain a better understanding of mechanical dyssynchrony and its 
efficacy in predicting the response to cardiac resynchronization therapy in HF patients.20, 21 
 
Ventricular Dyssynchrony and Narrow QRS 
The evidence found in literature highlight the fact that QRS duration does not correlate with 
intraventricular dyssynchrony and has only a limited relationship with interventricular 
dyssynchrony.22  In a model with narrow QRS complex, we observed significant LV 
dyssynchrony and non-significant RVLV delay, which is in accordance with previous reports.  In 
fact, QRS duration incorporates both right and left ventricular activation, and one’s delayed 
activation can be balanced by the other’s rapid activation.  In so doing, a normal QRS complex is 
preserved, in spite of a significant LV mechanical dyssynchrony.  In the current study, while 
disparity in the timing of ventricular mechanical contraction was obviously affected by levels of 
dobutamine stress, no specific alteration was observed in the duration of the QRS complex. 
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Dobutamine Stress and Ventricular Dyssynchrony  
A limited number of echocardiographic studies have specifically addressed the effect of stress on 
mechanical dyssynchrony in DCM patients with narrow QRS complexes.4-7  In these studies, 
three distinct groups of patients could be identified based on a specific dyssynchrony parameter: 
the first group showed no difference between rest and stress, the second showed an induced 
dyssynchrony when going from rest to stress, and the last showed a normalized dyssynchrony 
when going from rest to stress.  The reason the patients manifested such variable responses to 
exercise or dobutamine stress is not clear.  What we observed in our study was the same response 
from all DCM subjects, with exactly the same induced pathology, in terms of LV intraventricular 
dyssynchrony parameters at stress.  Based on our regional analysis, improvement of LV 
mechanical dyssynchrony at stress was attributable to the early contraction of previously delayed-
contracting regions that were mostly seen in the LV apex and septum.  Our observations concur 
with the evidence collected by Somsen et al., according to whom the septal wall is the typical site 
of dyskinesia and reduced contractility in patients with DCM,23 as well as with a recent canine 
study performed by strain echocardiography which showed a larger decrease on strains of apical 
segments in DCM dogs.12  Under induced stress, only the late septal contraction was normalized.  
The absence of any protection from the mitral annulus and papillary muscles in the apex could be 
the cause of severe tachycardia-induced effects in this region rather than on other walls at the 
time of evolution of LVDCM.12 
 Intermediate levels of dobutamine stress caused significant changes in homogeneity of 
contraction and ventricular function in the DCM cohort.  Applied LV dyssynchrony indices 
allowed for a clear distinction between those changes during the various stages of stress.  Even in 
control subjects, CHI and entropy sensitivity were promising in specifying the dyssynchrony 
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variations during the stress condition.  This observation concurred with what was previously seen 
in wall thickening-derived CHI and entropy when these were used to evaluate stress 
dyssynchrony in a control group.24  However, because phase values were well peaked in control 
subjects, phase SD could not show the small variances during the induction of dobutamine stress.  
Overall, our LV dyssynchrony parameters did not contradict, but rather complemented, each 
other in the stress analysis, in contrast to the previously seen discordance between the parameters 
of dyssynchrony measured by stress echocardiography in HF patients.5 
 In the current study, interventricular mechanical dyssynchrony was found to be 
insignificant in DCM subjects compared to their normal counterparts.  A similar observation was 
made by another group who showed that interventricular mechanical dyssynchrony is less 
frequently noted in HF patients with narrow QRS complexes.25  The main point here is the 
variability of the baseline direction of contraction (1 out of 10 subjects with positive RVLV 
delay), also seen in the control group (2 out of 8 dogs showed positive RVLV delays).13  
Moreover, there was an individual difference in the magnitude and pattern of change in RVLV 
delays during the dobutamine stress that was also seen in the control group.  We could not 
explain the reason for such variability in RVLV delays between individuals, which might be 
related to individual cardiac mechanical characteristics.  
 
Limitations 
The current study was performed in dogs; consequently, even though the applied methodology 
may seem transferable, our findings are not directly transferable to humans.  The number of 
animals was limited in this study.  The inadequate number of subjects, as well as inter-animal 
variability in RVLV delays, precluded any definitive conclusion about the effects of maximum 
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stress in interventricular dyssynchrony.  Due to the limited spatial resolution of the SPECT 
system, we relied on a count-based analysis to quantify dyssynchrony indices, an alternative 
superior to volume-based measurements, since it is more reproducible and accurate.  The 
apparent ventricular movement was actually the movement of the blood-endocardial interface.  
Consequently, a global cardiac motion was also present during ventricular systole along with 
myocardial contraction, which made it impossible to distinguish the real endocardial movements.  
Although the global cardiac motion was likely to be small in LV, it could severely affect the RV 
due to its geometrical shape.  For this reason, we did not measure the RV intraventricular 
dyssynchrony indices. The best scenario for RV was probably to be in synchrony with the LV 
which is thicker and more concentric (RVLV delay).  Finally, differences in synchrony between 
rest and stress episodes could be interpreted as being due to a better image resolution and count 
statistics caused by higher heart rates rather than by the intrinsic physiologic effects of stress.  
This hypothesis was previously evaluated by positron emission tomography and results revealed 
that count statistics are not responsible for the difference in dyssynchrony indices at stress.26  
However, this might not be as clear-cut in the case of SPECT images when image quality and 
count statistics are different. 
 
 
New knowledge gained 
Stress ventricular dyssynchrony analysis can be assessed in a straightforward and fully automated 
manner by phase analysis of GBPS imaging.  Different levels of dobutamine stress, even in close 
intervals, can have a significant impact on intraventricular dyssynchrony parameters in DCM 
subjects with narrow QRS complexes.  The changing trends are mostly seen as going toward the 
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perfection of synchrony.  The dyssynchrony indices of CHI, entropy, and phase SD have the 
same sensitivity to distinguish between various stress levels in DCM subjects. 
 
 
Conclusion 
In this study with a non-ischemic DCM model and narrow QRS complex, GBPS could identify 
the extent and pattern of ventricular contraction dyssynchrony at rest and during dobutamine 
stress levels.  Different levels of functional stress, even in close intervals, made significant 
positive changes in hemodynamic and intraventricular dyssynchrony parameters.  Since evidence 
of stress-induced mechanical dyssynchrony may be helpful in predicting the response to cardiac 
resynchronization therapy, further research is warranted to assess whether lower ventricular 
mechanical dyssynchrony indices induced by stress and measured by GBPS have the ability to 
predict the response to resynchronization therapy.  
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Tables 
Table 2-1: Functional parameters at rest and during levels of dobutamine-induced stress in DCM dogs 
Index Dobutamine (µg/kg/min) 
0 2.5 5 10 20  
      
HR (bpm) 107.1±10.5 112.7±12.2 117.8±12.4*# 125.7±11.7*#ǂ 134.7±12.2*#ǂ¶ 
QRS interval 79.1±10.2 80.4±9.7 79.5±9.5 78.1±8.7 78.2±7.7 
LVEDP 16.9± 5.5 16.8± 8.5 16.5± 8.5 13.7± 9.1 16.1± 10.7 
dP/dtmax 949.5±238.5 1343.2±277.3* 1660.5±296.9*# 2309.7±396.9*#ǂ 3020.8±568.9*#ǂ¶ 
LVEDV (ml) 129.5±34.1 124.2±35.8 118.4±34.5 115.4±34.7 110.3±39.1 
LVESV (ml) 97.4±29.3 84.3±26.4* 74.8±25.0*# 66.5±24.2*#ǂ 56.7±22.0*#ǂ¶ 
LVSV (ml) 29.2±11.0 36.6±14.6 41.5±13.3* 46.3±12.6*#ǂ 52.2±17.2*# 
LVEF (%)  22.6±6.0 29.5±7.5* 35.2±5.5*# 41.0±5.9*#ǂ 48.1±5.8*#ǂ¶ 
RVEDV (ml) 94.2±28.8 87.1±29.5 82.0±25.8* 80.6±24.2* 82.7±25.8 
RVESV (ml) 80.0±26.8 67.8±26.8 59.2±20.2* 55.5±19.2*#ǂ 53.5±21.7*# 
RVEF (%)  15.8±4.5 23.1±7.5* 28.3±4.5*# 32.1±7.6*# 36.9±9.8*#ǂ 
CO_Cb 3.1±1.1 4.2±1.8 4.9±1.7* 5.8±1.8*#ǂ 7.1±2.6*#ǂ 
CO_Th 3.8±2.0 6.0±3.1* 7.4±3.2* 9.4±4.0*# 11.7±5.2*# 
N=10 for all parameters except CO_Th and dP/dtmax (N=8) for DCM dogs.  Data are presented as mean ± SD. *= P ≤ 0.05 vs baseline; 
# = P ≤ 0.05 vs 2.5; ǂ = P ≤ 0.05 vs 5; ¶ = P ≤ 0.05 vs 10 µg/kg/min (RM ANOVA, Tukey).  HR, heart rate; QRS interval, QRS 
complex duration; LVEDP, left ventricular end-diastolic pressure; dP/dtmax, maximum rate of LV pressure change; LVEDV and 
RVEDV, left and right end-diastolic volume; LVESV and RVESV, left and right end-systolic volume; LVSV, left ventricular stroke 
volume; LVEF and RVEF, left and right ventricular ejection fraction; CO_Cb, cardiac output by count-based method; CO_Th, cardiac 
output by thermodilution method. 
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Table 2-2: Dyssynchrony parameters at rest and during dobutamine-induced stress levels in DCM vs control dogs 
 Index Dobutamine (µg/kg/min) 
 0 2.5 5 10 20  
DCM       
 LVCHI (%) 78.6±10.9 84.5±9.4 89.8±5.2* 90.6±5.4*# 92.4±3.9*# 
 LV Entropy 0.78±0.09 0.71±0.11 0.65±0.09*# 0.63±0.09*# 0.59±0.08*#ǂ 
 LV Phase SD (°) 49.4±14.8 41.0±14.9 33.3±10.6*# 31.9±12.2*# 27.1±10.7*# 
 RVLV delay (°) -20.9±21.1 -14.1±13.9 -16.8±10.2 -19.6±10.7 -22.2±11.5 
 RVLV delay (ms) -33.3±33.4 -20.3±19.4 -23.4±13.9 -25.8±14.5 -27.6±14.6 
Control       
 LVCHI (%) 96.4±1.3 97.9±0.6 98.7±0.9* 98.6±1.0 98.4±1.2 
 LV Entropy 0.52±0.04 0.43±0.03* 0.36±0.09* 0.37±0.10 0.38±0.01 
 LV Phase SD (°) 25.4±5.1 17.8 6.4 12.8±7.7 13.6±8.0 15.0±10.3 
 RVLV delay (°) -6.3 ±2.6 -10.7±3.4 -19.3 ±1.4* -21.3±3.6* -21.6 ±3.1* 
 RVLV delay (ms) -13.9 ±11.8 -17.2 ±13.7 -17.8 ±7.6 -23.8 ±9.5 -23.5 ±11.5  
N=10 for DCM dogs. N=8 for Normal dogs.  Data are presented as mean ± SD. *= P ≤ 0.05 vs baseline; # = P ≤ 0.05 vs 2.5; ǂ = P ≤ 0.05 
vs 5; ¶ = P ≤ 0.05 vs 10 µg/kg/min (RM ANOVA, Tukey).  LVCHI, LV contraction homogeneity index; RVLV delay, interventricular 
delay. 
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Table 2-3: Comparison of LV dyssynchrony and functional parameters between DCM and control dogs. 
  Rest   Maximum stress 
  Normal   DCM   P value   Normal   DCM   P value 
HR (bpm) 112.1±19.1  107.1±10.5  0.49  182.9±15.6  134.7±12.2  <0.0001 
QRS interval (ms) 76.5±5.7  79.1±10.2  0.52  71.1±9.0  78.2±7.7  0.09 
LVEDV (ml) 52.2±15.7  130.1±34.3  < 0.0001  37.4±14.5  110.3±39.1  0.0001 
LVESV (ml) 30.9±7.0  97.8±29.4  < 0.0001  16.7±2.8  56.7±22.0  0.0001 
SV (ml) 25.8±9.4  29.2±11.0  0.49  31.3±12.3  52.2±17.2  0.01 
LVEF (%)  49.5±8.4  22.6±6.0  < 0.0001  69.9±12.4  48.1±5.8  0.0001 
dP/dtmax (mmHg/s) 1588±374  949.5±238.5  0.001  8004±710  3020.8±568.9  < 0.0001 
CO_Cb (L/min)  2.8±1.0  3.1±1.1  0.55  5.7±2.2  7.1±2.6  0.24 
CO_Th (L/min)  3.2±1.3  3.8±2.0  0.47  7.9±4.2  11.7±5.2  0.13 
LVCHI (%) 96.4±1.3  78.6±10.9  0.0003  98.4±1.2  92.4±3.9  0.0008 
LV Entropy 0.52±0.04  0.78±0.09  0.0001  0.38±0.10  0.59±0.08  0.0002 
LV Phase SD (°) 25.4±5.1  49.4±14.8  0.0005  15.0±10.3  27.1±10.7  0.03 
RVLV delay (°) -6.3±2.6  -20.9±21.1  0.08  -21.6±3.1  -22.2±11.5  0.91 
RVLV delay (ms) -13.9±11.8   -33.3±33.4   0.14   -23.5±11.5    -27.6±14.6   0.53 
N=10 for all parameters except CO_Th and dP/dtmax (N=8) in DCM dogs. N=8 for all except dP/dtmax at 20 µg/kg/min dobutamine 
(N=6) in control dogs.  Data are presented as mean ± SD.  Abbreviations are the same as previous Tables. 
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Abstract 
Background:  It is still not known whether biventricular (BiV) pacing is the best pacing 
mode in every patient with atrioventricular block (AVB) and normal function and 
whether the optimal pacing mode at rest can be the best one during the exercise. 
Methods:  Five large dogs were submitted to AV node ablation and pacing leads were 
placed in the right atrium for sensing, in the right ventricular (RV) apex, and in 
posterolateral LV vein for pacing in five modes of left ventricular (LV), BiV with 20 ms 
of LV pre-activation (LVRV20), BiV, BiV with 20 ms of RV pre-activation (RVLV20) 
and RV pacing.  Stress was induced by administering intravenous dobutamine up to a 
maximum of 20 μg/kg/min.  Hemodynamic and dyssynchrony data were analyzed by LV 
pressure measurements and gated SPECT myocardial perfusion (GMPS) phase analysis 
by either the QGS or MHI4MPI software.   
Results:  A significant LV dyssynchrony was seen at LV pacing versus other 
interventions which was normalized at maximum stress level (bandwidth: 177.6º ± 41.7º 
at rest vs 68.4º ± 21.0º at maximum stress).  Although RV pacing produced lower 
contraction homogeneity (THI) mostly cause of lowered amplitude (THI: 90.3% ± 
10.3%) at rest, it was improved at 5 μg/kg/min level (97.2% ± 2.3%) and remained stable 
at higher stress level.  At maximum stress, LV dyssynchrony was further normalized at 
LV-based pacing modes and worsened at BiV or RV-based pacing modes. LVRV20 
pacing showed the lowest degree of LV dyssynchrony versus single-site pacing modes at 
maximum stress (entropy: 37.8% ± 3.0% in LVRV20 vs 52.6% ± 5.3% in LV pacing and 
51.0% ± 8.2% in RV pacing).   
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Conclusions:  Stress changed the extent of resting LV dyssynchrony at all the pacing 
modes and resulted in more accurate dyssynchrony assessment with lesser variability in 
our subjects than the resting condition.  BiV pacing with pre-activation of the LV closely 
resembled the intrinsic ventricular activation in developing normal mechanical 
contraction at higher levels of stress. 
 
Keywords: Left ventricular dyssynchrony . gated myocardial perfusion SPECT . 
dobutamine stress . atrioventricular block and normal function.  
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Introduction 
Ventricular pacing is an inevitable treatment in patients with congenital or acquired 
atrioventricular block (AVB) for eliminating the bradycardia as a trigger for initiation of 
ventricular arrhythmia and further dysfunctions.1  Right ventricular apex (RVA) pacing 
has been the ideal site of stimulation for decades in patients with AVB and typically 
normal ventricular activation pattern and normal systolic function.2  However, 
recognition of deleterious effects of RVA pacing on left ventricular (LV) function,3,4 
mechanical synchrony,5,6 and structure7 has shifted the interest toward the alternative 
pacing modes.  
Among pacing alternatives which are routinely used for different heart failure 
patients with intraventricular conduction disorders, simultaneous biventricular pacing 
(BiV) has been mostly considered by both preclinical and clinical studies in patients with 
AVB and normal ventricular function.8-11  Comparative acute and chronic studies of the 
effects of RVA and BiV pacing confirmed the superiority of BiV pacing in preserving the 
LV performance and function due to inducing a more physiologic and synchronous 
ventricular activation sequence in such patients.8-11  While, it is still not known whether 
BiV pacing is the best mode in every patient with AVB and normal function, other types 
of stimulation have rarely been studied in such patients.  Also, it is unknown whether the 
optimal pacing mode at rest can be the best one during the exercise and increased heart 
rates in these patients.  
The potential mechanism in the superiority of BiV pacing is thought to be related to 
the mechanical dyssynchrony as studied by echocardiography.9,11  Considering the fact 
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that echocardiographic techniques are not reliable in LV dyssynchrony measurements due 
to high inter and intra-observer variability,12 it is of special interest to verify the 
dyssynchrony produced by different ventricular activation sequence, especially at stress, 
with a more reliable, reproducible though possibly an automated imaging modality.  In 
comparison with echocardiography, phase analysis of gated single-photon emission 
computed tomography (SPECT) myocardial perfusion imaging (GMPS), has been shown 
to be highly repeatable and reproducible for LV dyssynchrony measurements.13   
Accordingly, we used phase analysis of GMPS to quantify the acute changes in LV 
function and mechanical synchrony during RV pacing compared to various pacing modes 
of LV, simultaneous and sequential biventricular pacing under the rest and dobutamine 
stress levels in a canine model of AVB and normal function.   
 
 
Methods 
 
Study Protocol 
The protocol was approved by the institutional Research Ethics Board and all procedures 
followed the Canadian Council on Animal Care.  Five adult dogs (mixed races; mean 
weight 38.3 ± 1.9 kg) underwent general anesthesia with isoflurane 1.5% after induction 
with doses of 5 mg/kg ketamine and 0.25 mg/kg diazepam.  SaO2 was monitored using a 
standard biomedical cardiac monitor (Eagle 4000, Marquette Medical System, 
Milwaukee, WI, USA).  The dogs’ bladders were catheterized in order to prevent 
radioactive urine spills.  A pressure catheter (Ventri-cath 507S, 5F, straight tip, Millar 
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Instruments, Houston, TX, USA) was inserted into the LV via the left carotid artery to 
monitor chamber pressure.  Signals were conditioned (MPVS Ultra 753-2083, Millar), 
digitized (ITF156, Emka Technologies, Falls Church, VA, USA) and subsequently 
analyzed with a dedicated software (Iox2, ver. 2.5.1.6, Emka).  It has to be mentioned 
that hemodynamic data were recorded for four dogs out of five because the Millar system 
was unavailable.  An access was positioned in the femoral venous of the left leg for 
dobutamine infusion.  Surface ECGs were recorded using a standard 3-lead configuration 
(Cardiac Trigger Monitor 3000, Ivy Biomedical Systems Inc., Branford, CT, USA).  At 
the end of the experiment, dogs were euthanized with the administration of isoflurane 5% 
and an intravenous overdose of potassium chloride. 
 
Pacing Protocol   
The atrioventricular (AV) node was ablated with a 4-mm electrode-tip radiofrequency 
ablation catheter (Cordis-Webster, Johnson, and Johnson).  Pacing leads were placed in 
the right atrium for sensing, in the RV apex (via the jugular vein guided by fluoroscopy), 
and in a branch of the coronary sinus (posterolateral LV vein) for pacing.  Devices were 
programmed in an atrial synchronous tracking mode without atrial pacing (VDD mode) 
for five pacing modes performed in a regular order as following: LV pacing, biventricular 
pacing with 20 ms of LV pre-activation (LVRV20), biventricular pacing (BiV), 
biventricular pacing with 20 ms of RV pre-activation (RVLV20) and right ventricular 
pacing (RV).  The optimal AV delay used for the protocol was individually adjusted 
during BiV pacing mode and was the smallest which provided no changes in 
hemodynamic properties. The AV delay was fixed for each set of tested configuration.   
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Dobutamine Stress GMPS Acquisition 
The GMPS and surface ECGs were simultaneously acquired at baseline and dobutamine-
induced stress levels of 5 and 20μg/kg/min for each pacing configuration.  First, baseline 
images were acquired with 99mTc-tetrofosmin (Myoview, GE Healthcare) at each pacing 
mode started from LV and continued by predetermined modes to the RV.  Radiotracer 
dose was adjusted to dogs’ weight.  Data were collected after 10 min of pacing at each 
configuration to achieve the equilibrium before data acquisition.  Then, cardiac stress was 
induced by a dobutamine infusion prepared in 500 μg/mL of normal saline solution and 
continuously infused over average times of 37.4 and 30.6 min while increasing the 
outflow to reach the predetermined dosage.  Because of dobutamine’s short half-life (≈ 
2.3 min), a continuous infusion was used to create a stable dobutamine stress effect 
allowing the acquisition of the SPECT images.  Immediately after reaching a target 
dobutamine concentration level, image acquisition was initiated for each of five pacing 
modes. There was no rest period during the entire experiment.   
 In average, the stress dobutamine effect for each level of 5 and 20 μg/kg/min 
lasted around 106.2 and 84.6 min which a total volume of 42.2 and 132.1 mL of solution 
was infused.  The duration of GMPS acquisition was adjusted throughout the day to reach 
equal count statistics in spite of 99mTc decay time; average time of image acquisition was 
8 min for each of pacing modes.  Cardiac hemodynamic, as well as cardiac contraction 
synchrony data (using GMPS) were recorded for each pacing mode at rest and during the 
stress levels.  Data were acquired on a dual-head gamma camera (e.cam; Siemens PA, 
USA), low-energy high-resolution collimators and 64 projections dispatched on a 360° 
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arc. The gated data were acquired as 16 frames per cardiac cycle and stored in a 64 × 64 
matrix.   
 
GMPS Data Processing and Phase Analysis 
All the gated data were reconstructed using a 2D-OSEM algorithm with 10 iterations and 
8 subsets and then filtered by a Gaussian filter of 8.4 mm with a reconstructed pixel size 
of 4.8 mm.  All reconstructed data were reoriented manually using a camera software 
package (Siemens Autocardiac 8.5.10.1) to produce gated short axis images which were 
then submitted to phase analysis of LV dyssynchrony assessment.  Short axis images 
were submitted into automatic segmentation QGS® 2009 software including the phase 
analysis plug-in (Cedars-Sinai Medical Center, Los Angeles, CA, USA).  LV 
dyssynchrony parameters throughout a cardiac cycle in QGS were phase histogram 
bandwidth (the width of the band with 95% of the samples over the entire LV), SD 
(standard deviation of the phase histogram) and entropy (the probability of occurrence of 
phase angle i in a phase histogram).14  As a note, entropy would be equal to zero when 
the synchrony of contraction is at the maximum level.14  In fact, in the case of reduced 
contraction consistency, entropy is able to identify the degree of random and 
uncoordinated contraction.  In addition, LV functional volumes, ejection fractions, and 
septal-to-lateral delay were obtained from this software.   
 Short axis images were also submitted into the automatic segmentation software 
MHI4MPI with thickening-based mechanical synchrony analysis measurement.  Details 
of segmentation and calculation of synchrony parameters have been previously described 
elsewhere.15  Briefly, after constructing the myocardial wall edges, a three harmonics 
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Fourier analysis was used to estimate the phase (timing) and amplitude of contraction in 
different walls of anterior, septal, inferior, lateral and apex.  In fact, the phase, measured 
as an angle, was the base of all synchrony parameters.  The cross-correlation of the 
septum and lateral mean thickening phases was used to obtain the thickening-based 
septal-to-lateral wall delay (TSLD) as an index of intraventricular mechanical synchrony.  
Also, the thickening homogeneity index (THI) which represents the proportion of wall 
thickening that is in synchrony with the average LV thickening was calculated as the 
mean efficiency, the portion of amplitude that is in the direction of mean phase, divided 
by the mean amplitude. 
 
Statistical Analysis 
Statistical analyses were performed using dedicated software (SPSS Statistics 21.0, 
Chicago, IL).  Also for graphical illustrations, we used the GraphPad Prism version 6.00 
for Windows (GraphPad Software, La Jolla, California, USA).  Data are reported as mean 
± SD.  QGS and MHI4MPI phase measurements, as well as functional parameters in 
different pacing modes under rest and stress levels were compared by a linear mixed 
model with levels of stress, type of stimulation and their interactions as fixed effects and 
with repeated measures on animals as random subjects using compound symmetry 
variance structure.  A dog with missing data in RVLV20 pacing at rest for the gating 
problem and a dog with missing data in LVRV20 pacing at 20 μg/kg/min dobutamine 
which was never made a mistake at the day of the experiment were included in the 
model.  Also, a dog with missing data in RV pacing at 20 μg/kg/min dobutamine due to 
the segmentation difficulty through the MHI4MPI software was included in the model.  P 
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< 0.05 was considered statistically significant.  Multiple comparisons were performed 
with Bonferroni's post-hoc test whenever the F-ratio for the factors was significant. 
 
 
Results 
Hemodynamic Data  
LV hemodynamic parameters in the effect of various pacing modes have been shown at 
rest and during dobutamine-induced stress levels in Table 1 and 2 respectively. At 
baseline, established LVEF and dP/dtmax indicated a normal systolic function, within the 
normal range,(15) in the effect of different pacing interventions.  However, a single 
favorable functional response cannot be seen among different pacing modes.  Both 
parameters were significantly improved during the levels of dobutamine stress during 
each of the stimulation patterns.  RV pacing did not indicate an increase in SV and 
cardiac output (CO) during the stress levels and had the lowest value among other 
stimulation modes during the maximum stress.  The reason why the CO and SV at RV 
pacing failed to reach a statistical significance with those of LVRV20 pacing, while the 
related values in LVRV20 pacing were fairly high relative to the RV pacing, could be the 
effect of a missing data in LVRV20 pacing mode and the expectation and replacement of 
that missing value in the statistical model.  In fact, the calculation of SV and CO requires 
two variables of EDV and ESV for the SV, and SV and heart rate for the CO, which 
because of missing data at each parameter, the expected error might be doubled during 
the LVRV20 pacing mode.  
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 The contractility index (CI) defined as the maximal rate of pressure rise 
normalized to instantaneous pressure (a contractility index with less load sensitivity) was 
profoundly improved during each pacing mode at maximum stress level but reached the 
statistical significance at BiV , RVLV20 and RV pacing interventions.  The reason of this 
significance was the augmented variance between the subjects at 20 μg/kg/min 
dobutamine in the mentioned pacing modes, while the mean values were nearly the same 
(Figure 3-1).  Heart rate was constantly increasing by the stress levels, no matter which 
pacing mode was used and BiV pacing showed a significantly higher heart rate in 
comparison with the LV pacing at maximum stress level. QRS duration was significantly 
higher in LV pacing compared to RV and RVLV20 both at baseline and stress levels. 
 
Regional Mechanical Contraction 
Regional LV phase delays were not significantly different from the LV mean phase at 
rest and 5 μg/kg/min dobutamine as shown in Figure 3-2 A, B.  During the LV and RV 
pacing, the standard deviation of the phase delays in some LV regions were remarkable at 
rest; however, it was largely reduced during the stress levels.  There was only a 
significant difference between inferior wall and mean LV contraction phase at maximum 
stress level during the LV and RVLV20 pacing modes (P = 0.04 and P = 0.03 at LV and 
RVLV20 pacing modes, respectively; Figure 3-2 C), showing an incomplete synchrony 
perfection at LV inferior wall during the LV pacing (despite more synchronous 
contraction in other walls) and a little synchrony decline at inferior wall during the 
RVLV20 pacing at maximum stress level.  Figure 3-3 A-J shows the thickening-based 
LV contraction phase of a dog at baseline and maximum stress level during various 
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pacing modes as an example.  As it has been shown, the pattern of contraction in regions 
of the LV is different during each pacing mode at rest. For instance, lateral and anterior 
walls of the LV at RV pacing contract according to different phases and amplitudes and 
later than mean LV phase.  Although the spatial distribution of the regions (phase and 
amplitude of LV regional contractions) has been improved at maximum stress level, they 
still show differences with the mean phase and amplitude.  Comparing the pacing modes 
with respect to the uniformity of contraction, LVRV20 shows the most homogeneous and 
coordinated regional contraction at maximum stress among other modes in this case 
(Figure 3-3 H).  
 
Dyssynchrony Parameters 
LV dyssynchrony parameters in the effect of various pacing modes have been indicated 
at rest and during dobutamine-induced stress levels in Table 3 and 4, respectively.  Also 
as an example, Figure 3-4 A-J shows phase analysis of GMPS as assessed by QGS 
software in a dog, same dog as shown in Figure 3-3, at rest and maximum stress while 
various pacing modes were applied.  LV pacing significantly increased the dyssynchrony 
in comparison with other interventions at rest based on bandwidth and phase SD.  It has 
to be mentioned that these parameters were significantly higher than the range reported 
previously for normal dogs (93.0° ± 38.8° with the range of 36°-150° for bandwidth and 
25.7° ± 11.7° with the range of 9.5°-44.4° for phase SD in normal dogs15).  Also, 
LVRV20 pacing had a significantly higher bandwidth compared to BiV and RVLV20 
pacing modes; however it is within the normal range.  SLD in LV pacing was 
considerable and negative in comparison with other pacing modes.  Also, LV pacing 
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showed a significant higher entropy versus BiV and RVLV20 pacing modes (LV: 60.0% 
± 3.0% vs BiV: 45.6% ± 8.2% and RVLV20: 47.7% ± 13.7%; P < 0.05).   
 Based on THI, the more synchronous contraction was seen during sequential 
pacing either LV first or RV and less synchronous one was seen for RV pacing 
stimulation.  However, both single-pacing sites indicated close values and were lower 
than BiV pacing in terms of homogeneity of contraction.  TSLD showed an early lateral 
wall contraction phase in LV pacing compared to other interventions meaning that the 
contraction of septum first happened in all other stimulations.  Thus, the phase delay 
between the lateral wall and septum did not differ between interventions and only the first 
contracted wall was different in LV pacing compared to other pacing modes at rest and at 
maximum stress.   
 During the stress, dyssynchrony (bandwidth and phase SD) was significantly 
diminished in LV based pacing modes. However, phase SD and entropy were still 
significantly higher in LV pacing in respect to the BiV-based pacing modes at 5 
μg/kg/min dobutamine level.  BiV and RV-based pacing modes did not show significant 
differences with each other at baseline; unless RV pacing had lower THI versus RVLV20 
pacing.  A considerable decrease in LV dyssynchrony (based on entropy) happened at 5 
μg/kg/min dobutamine-induced stress at these pacing modes while further stress level 
returned the dyssynchrony to the baseline value.  LVRV20 pacing showed further 
decrease in entropy at maximum stress relative to the single pacing sites.  Moreover, at 
maximum stress level, sequential pacing modes evoked the least entropy compared to 
both single site pacing modes.  High SLD during LV pacing was normalized and 
significantly decreased during both levels of stress.  THI was significantly improved in 
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single-site ventricular pacing modes with the intermediate level of dobutamine and 
remained constant through further stress level.  However, the THI in other BiV pacing 
modes were already high at baseline and did not significantly change.  Additionally, the 
amplitude of contraction was considerably augmented in all the pacing modes at 5 
μg/kg/min dobutamine and only under the RV pacing further improvement was seen in 
the magnitude of contraction with maximum stress level (Figure 3-5). 
 
 
Discussion 
The actual incidence of pacing-induced cardiomyopathy is not clear in patients with 
normal LVEF due to non-subgroup analysis in most studies; however, it seems to be 
lower than patients with a depressed LVEF.16  Although priority of BiV over RV pacing 
has been shown by PACE trial which was particularly designed for patients with 
bradycardia and preserved LVEF,10,11 based on a recent long-term study, the use of 
preventive BiV pacing has no clinical benefits in terms of heart failure (HF) 
hospitalizations or mortality in patients with AVB.17  Consequently, indications for BiV 
pacing in patients with preserved LV function who require long-term pacing is still not 
well-defined in current guidelines and it is still not known whether it is the best mode in 
every patient with AVB and normal function.  However, the identification of LV 
dyssynchrony may help to select a subgroup that could benefit from an alternative pacing 
as it was successfully used to predict the response of HF patients to cardiac 
resynchronization therapy (CRT).18   
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 In this study with a model of AVB and normal function, we could not find a 
significantly better acute response with BiV rather than RV pacing regarding the 
synchrony of mechanical contraction at rest or stress levels.  It is in contrast to the 
findings of a previous echocardiographic study showing that BiV pacing could induce 
lower LVSLD in comparison with the RV pacing in an immature animal model of AVB 
and normal function.9  Interestingly, rather than BiV pacing, sequential pacing modes 
were the most prominent in reducing the contraction dyssynchrony compared to the RV 
pacing at rest and at maximum dobutamine stress in our study.  This finding may bring 
new idea about using individual optimization of the interventricular delay (sequential 
pacing), which has been a recognized strategy in patients receiving CRT, to improve the 
long-term response of the patient.  However, this hypothesis must be verified by the 
clinical comparative trials.  
 Alteration of the pacing modes did not induce a significant difference in acute 
hemodynamic response in our model either at rest or at stress levels.  All hemodynamic 
parameters were considerably improved with the administration of dobutamine stress 
during each of the pacing modes.  Only the RV pacing did not make a change in SV and 
CO with the maximum stress level and showed significant difference with other 
interventions at this stress level.  The reason could be observed by the non-significant 
difference in synchrony with the RV pacing during the maximum activity as assessed by 
the phase parameters.  Although the amplitude of contraction was significantly increased 
with the dobutamine stress levels during the RV pacing, it still did not make considerable 
effects on the hemodynamic results.  
 133 
 
 It is worth mentioning that the LV dyssynchrony results measured by QGS or 
MHI4MPI software did not contradict, but rather complemented, each other in the stress 
analysis in contrast to the disagreement formerly seen between the parameters of 
dyssynchrony measured by stress echocardiography.19  Hence, various components of 
mechanical contraction (phase and amplitude) by variables of both methods were used in 
this study.  At baseline, decreased amplitude during the RV stimulation offset the 
increased uncoordinated contraction phase during the LV pacing to achieve a comparable 
amount of ventricular homogeneity about 90% using single-site pacing modes.  Thus, the 
randomness of the phase of contraction at baseline was more prominent during the LV 
pacing versus BiV and RV-based pacing modes at rest which did not reflect any sensible 
effect on ventricular contractility.  Also , by LV pacing longer time was needed to 
activate the entire ventricles relative to using RV-based pacing modes and this electrical 
dyssynchrony remained constant at maximum stress level, despite mechanical synchrony 
was significantly improved.  Although the electrical dyssynchrony matched the 
mechanical dyssynchrony at resting condition, the link was faded away at maximum 
stress level.  Based on a comprehensive study in normal subjects, QRS duration is not 
sensitive to the variation of heart rates and activity levels.20  Although in our model, the 
electrical stimulations were propagated through various sites and different myocardial 
pathways rather than the Purkinje system, their behavior with the increased heart rates 
was the same as normal electrical propagations and did not change with activity levels.  
Moreover, QRS duration incorporates the electrical activation timing of both ventricles, 
not the mechanical activation of LV. Also, it has been previously proved that it does not 
correlate with intraventricular dyssynchrony.21 
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 Although the LV-induced dyssynchrony was normalized significantly through the 
5 μg/kg/min dobutamine, synchrony improvement was seen in all the pacing modes 
resulted in an identical pattern of difference between the LV and other pacing modes at 
baseline.  Further stress level made the considerable decline in synchrony of mechanical 
contraction (entropy) at BiV and RV-based pacing modes, enforced them to return the 
baseline values.  Thus, improvement in LV synchrony remained stable over a range of 
heart rates and activity levels only in LV-based pacing modes.  Moreover, LVRV20 
pacing was the most effective stimulation which produced maximum LV synchrony with 
98% THI at stress condition.  The reason why the electrical stimulation induced from 
BiV pacing with pre-activation of the LV develops a progressing synchrony with 
increasing the levels of stress may be found in the timing of electrical propagation 
through the normal ventricular myocardium.  Since more time is needed for the LV 
epicardial wavefronts to move transmurally toward the endocardium relative to the RV 
endocardial wavefronts from RV apical site,22 earlier proceeding of electrical signals 
from the LV site and, with a time interval, from the RV endocardium can make a 
coincidence in myocardial activation from both sites which may provide a proper timing 
synchrony in ventricular contractions.  As it has been shown in the current study, higher 
heart rates do not hamper this activation coincidence but rather strengthen, making the 
synchrony of mechanical contractions more efficient. 
  Dobutamine stress may induce regional differences in myocardial contractility, 
thus may change the presence and extent of LV dyssynchrony either in normal subjects or 
heart failure patients.15,19  Our results, in accordance with the previous findings, show that 
clear synchrony differences exist between the rest and stress episodes in subjects with 
 135 
 
AVB and normal function submitted to various pacing modes.  The aforesaid difference 
could be mostly due to the intrinsic physiologic effects of stress rather than better image 
resolution and count statistics at higher heart rates, as previously been examined.23  
Dobutamine-induced variation in dyssynchrony parameters was positive at the level of 5 
μg/kg/min dobutamine for all the pacing interventions. However, further stress level up to 
20 μg/kg/min dobutamine did not make a considerable change at LV-based pacing modes 
and even worsened the synchrony of contraction at BiV or RV-based pacing modes.  The 
variation was attributed to the extent of approaching to or moving away from the mean 
LV contraction phase, amplitude or both together.   
 It is worth mentioning that the inter-subject variability in mechanical response to 
the pacing stimulations was substantially decreased with the administration of 
dobutamine stress according to the phase parameters.  Since high variability reduces the 
ability to detect statistical significance, assessing the LV dyssynchrony under stress 
allows a better statistical power mostly in the case of using small sample sizes. 
 
Limitations 
The number of subjects was limited in this study.  Moreover, the number of imaging 
sessions and data collected from each animal was very high that made it impossible to 
record all the information without any missing data.  We used the GMPS for acquiring 
the volumes and LVEFs which might not be an ideal method for the accurate 
measurements.  Also, focusing only on the dP/dtmax and contractility index was 
insufficient and might neglect many other aspects of systolic function and ventricular 
performance affected by pacing interventions.  
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Conclusion 
In this study with a model of AVB and normal function, GMPS could clearly identify the 
pattern of LV regional contraction and the extent of LV dyssynchrony at rest and at 
dobutamine stress levels while various pacing modes were applied.  The mechanical 
response of the LV myocardium to a specific type of pacing intervention may be 
overestimated or underestimated at rest.  However, intrinsic physiologic effects of stress 
result in a more accurate dyssynchrony assessment with lesser variability in subjects 
underwent pacing.  BiV with LV pre-activation seems to be the preferred site of 
stimulation in this model rather than single-site pacing mode.  Due to the importance of 
ventricular pacing in patients with AVB and concerns about the generated ventricular 
dyssynchrony with pacing, further research is warranted in a larger group to assess if the 
stress dyssynchrony measured by GMPS could be efficient as a method for optimizing 
the pacing in these patients.  
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Figure 3-3: Thickening-based LV contraction phase of a dog during various pacing 
interventions at baseline (A-E) and at 20 μg/kg/min dobutamine (F-J) as an example.  
Each of the 400 dots contains both amplitude and phase of an actual vertex on the LV 
surface.  They are expressed as a complex harmonic which contains both amplitude and 
phase, represented in a polar coordinate system with a radius and angle that correspond to 
amplitude and phase, respectively.  The average amplitude (normalized to the percentage 
of average thickening) is presented by the circle and the average phase direction is 
represented by the line.  The average efficiency presented by small circle is the projection 
along the direction of the mean phase and is negative if the vertex phase differs from the 
mean phase for more than a quarter of the cardiac cycle.  While there is some sort of 
uncoordinated contraction at rest, in particular during RV and LV pacing, stress forced 
the LV walls to contract more homogeneously using increased amount of amplitude in 
nearly all pacing stimulations, especially during LVRV20 pacing.  
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Tables 
 
Table 3-1: LV hemodynamic parameters in effect of various pacing modes at rest. 
Index 
Dobutamine (µg/kg/min) =0 
LV LVRV20 BiV RVLV20 RV 
HR (bpm) 117.3±22.6§º 116.6±22.8§º 115.6±22.9§º 113.9±23.0§º 113.7±22.3 §º 
QRS-
interval (ms) 
139.6±9.3 129.4±7.7 114.2±7.1 105.5±17.3* 100.3±26.4* 
dP/dt max 
(mmHg.s-1) 
1348±402§º 1449±514§º 1455±524§º 1339±511§º 1351±438§º 
EDP(mmHg) 6.1±1.5 5.5±1.6 5.5±1.7 5.8±1.8 6.4±1.7 
CI (s-1) 54.5±19.8 50.0±14.8 50.4±16.4§ 45.4±12.6§ 45.8±13.3§ 
EDV (mL) 43.8±15.3 43.2±16.8 42.8±15.7 43.5±14.5 42.8±17.6 
ESV (mL) 25.4±11.1 º 25.4±12.0§º 26.0±13.4§º 27.3±11.9§º 25.8±14.1§º 
LVEF (%) 42.6±11.3§º 42.6±10.0§º 41.4±11.5§º 40.5±9.4§º 42.2±9.8§º 
SV (mL) 18.4±6.4§º 17.8±6.2§º 16.8±3.8§º 16.1±5.4§º 17.0±4.1 
CO (L/min) 2.4±0.5§º 2.3±0.3§º 2.1±0.3§º 2.1±0.4§º 2.1±0.2 
N=4. Data are presented as mean ± SD. P < 0.05 vs LV=*; RV=¥, LVRV20=¶; 
dobutamine levels of 5= º and 20 µg/kg/min =§.  HR: heart rate; dP/dt max, maximum rate 
of rise of LV pressure; EDP, end diastolic pressure; CI, contractility index; EDV, end-
diastolic volume; ESV, end-systolic volume; LVEF, left ventricular ejection fraction; SV, 
stroke volume; CO, cardiac output. 
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Table 3-2: LV hemodynamic parameters in effect of various pacing modes during dobutamine-induced stress levels. 
Index 
Dobutamine (µg/kg/min) =5 
  
Dobutamine (µg/kg/min) =20 
LV LVRV20 BiV RVLV20 RV LV LVRV20 BiV RVLV20 RV 
HR (bpm) 136.6±15.2 136.8±15.1 136.5±15.7§ 135.3±16.1 132.2±14.2  135.2±14.7 145.5±19.9 153.1±31.8* 141.8±19.0 138.6±16.8 
QRS-interval 
(ms) 
138.6±8.3 128.8±9.0 118.9±16.2 100.3±11.8* 104.3±19.3*  140.0±5.5 117.7±13.1 108.3±15.4* 91.7±16.3* 107.0±25.3* 
dP/dt max 
(mmHg.s-1) 
3194±1330 3565±1761 3625±1961 3411±1834 2875±976  4522±896 4586±939 4454±934 4340±939 4093±1035 
EDP (mmHg) 5.7±1.5 4.8±1.1 5.3±1.2 5.0±1.2 5.1±1.4  7.7±1.2 5.8±1.7 9.6±5.6 10.2±8.4 9.5±5.9 
CI (s-1) 70.9±20.1 62.5±18.9 61.7±18.9 58.6±21.2 57.8±17.8  89.3±14.8 90.1±23.1 92.1±31.5 86.2±36.2 90.1±47.9 
EDV (mL) 42.8±12.6§ 42.0±10.9 42.6±10.2 41.6±11.4 37.6±10.2  51.0±12.2¥ 45.3±12.2 46.7±11.1¥ 46.8±12.6¥ 35.8±8.0 
ESV (mL) 17.8±5.5 16.4±5.4 17.8±4.9 18.2±5.9 17.8±5.1  19.0±5.5 17.4±5.3 17.8±4.1 18.0±4.3 14.4±4.5 
LVEF (%) 57.6±11.4 59.6±11.4 57.4±9.9 55.8±9.6 52.4±7.3  63.0±7.8 58.6±10.3 60.0±7.8 60.0±9.0 59.6±8.0 
SV (mL) 25.0±9.8§ 25.6±9.2 24.8±9.2 23.4±8.1 19.8±6.6  32.0±9.1¥ 28.0±10.2 29.0±8.7¥ 28.8±10.8¥ 21.4±4.8 
CO (L/min) 3.8±0.8 3.8±1.0 3.7±1.4 3.4±1.0 2.8±0.7  4.8±1.0¥ 4.3±1.0 4.7±1.4¥ 4.5±1.1¥ 3.2±0.3 
N=4. Data are presented as mean ± SD. P < 0.05 vs LV=*; RV=¥, LVRV20=¶; dobutamine levels of 5= º and 20 µg/kg/min =§. 
HR, heart rate; dP/dt max, maximum rate of rise of LV pressure; EDP, end diastolic pressure; CI, contractility index; EDV, end-
diastolic volume; ESV, end-systolic volume; LVEF, left ventricular ejection fraction; SV, stroke volume; CO, cardiac output.
 149 
 
Table 3-3: LV dyssynchrony parameters in effect of various pacing modes at rest. 
Index 
Dobutamine (µg/kg/min) =0 
 LV LVRV20 BiV RVLV20 RV 
QGS measurements 
Bandwidth 
(º) 
 177.6± 41.7§º 92.4± 44.6*§º 50.4± 23.8*¶ 49.2±22.2*¶ 73.2±30.4*º 
Phase SD (º)  47.4±12.2 §º 26.3±11.3*§º 17.3±7.7*º 12.8±6.0*¶ 18.8±8.6*º 
Entropy (%)  60.0±3.0 º 51.8±8.0 §º 45.6±8.2*º 47.7±12.1*º 53.6±10.9º 
SLD (º)  -27.3±25.5 -1.4±18.6* 8.3±15.9* 12.7±10.5* 5.7±13.7* 
MHI4MPI measurements 
THI (%)  91.9±4.3 º 97.6±1.3¥ 95.0±4.3 97.6±1.3¥ 90.3±10.3§º 
TSLD (º)  -8.1±4.5 4.7±5.7* 7.8±8.6* 5.9±8.3* 7.8±16.3* 
N=5. Data are presented as mean ± SD. P < 0.05 vs LV=*; RV=¥, LVRV20=¶; 
dobutamine levels of 5= º and 20 µg/kg/min =§. SLD, septal-to-lateral delay; THI, 
thickening homogeneity index; TSLD, thickening septal-to-lateral delay 
.
 150 
 
Table 3-4: LV dyssynchrony parameters in effect of various pacing modes during dobutamine-induced stress levels. 
Index 
Dobutamine (µg/kg/min) =5  Dobutamine (µg/kg/min) =20 
 LV LVRV20 BiV RVLV20 RV  LV LVRV20 BiV RVLV20 RV 
QGS measurements 
Bandwidth(º)  72.0±52.1 32.4±8.0* 33.6±6.8* 31.2±9.9* 40.8±10.7  68.4±21.0 40.3±18.1 44.7±11.4 44.4±19.7 52.8±15.5 
Phase SD (º)  22.0±12.3 7.8±2.0* 7.3±2.0* 6.9±1.7* 10.0±3.0*  18.7±4.3 8.8±4.5* 11.4±2.2 12.1±4.3 13.5±3.3 
Entropy (%)  51.0±7.0 38.8±6.3* 36.0±7.8*§ 35.4±5.2* 41.8±6.8§  52.6±5.3 37.8±3.0*¥ 48.4±6.5 42.2±10.8* 51.0±8.2 
SLD (º)  -15.0±5.2 2.1±2.5 9.5±4.4* 2.7±3.7 10.8±5.0*  -17.2±7.3 0.2±3.2 10.0±6.0* 10.7±8.4* 11.6±9.4* 
MHI4MPI measurements 
THI (%)  97.9±0.9 97.9±0.8 98.7±0.4 98.0±1.9 97.2±2.3  96.3±2.0 98.5±0.5 95.0±2.8 95.7±2.4 97.1±0.6 
TSLD (º)  -2.3±3.1 2.3±5.0 7.3±2.6 4.6±7.5 10.0±8.5*  -8.2±6.4 4.1±4.7* 11.8±9.4* 14.8±12.7* 7.4±8.8* 
N=5. Data are presented as mean ± SD. P < 0.05 vs LV=*; RV=¥, LVRV20=¶; dobutamine levels of 5= º and 20 µg/kg/min =§. 
SLD, septal-to-lateral delay; THI, thickening homogeneity index; TSLD, thickening septal-to-lateral delay.  
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Discussion and Conclusion 
The current thesis was set out to explore the robust and accurate methods for quantifying 
mechanical dyssynchrony (MD) and also the role and impact of functional stress on inter- and 
intraventricular MD in three different experimental models of control, DCM, and AV block 
submitted to ventricular pacing.   
 The overall literature on ventricular “MD” subject and specifically in the context of 
“stress dyssynchrony” is inconclusive on several vital questions. The thesis sought to answer 
three of these questions:  
1. Which nuclear methodology is more accurate and robust in the assessment of stress-
MD? 
2. What is the range of difference in inter- and intraventricular MD parameters when the 
patient is submitted to various levels of functional stress? 
3. Is the optimal pacing solution at rest in terms of synchrony of contraction also the best 
one during the exercise and increased heart rates? 
The response to these questions was searched and proposed as three manuscripts within the 
respective chapters. The main findings can be summarized here as following:  
 
1. Which nuclear methodology is more accurate and robust in the assessment of stress-
MD? 
In the current thesis, two nuclear techniques of GMPS and GBPS were utilized for stress-MD 
assessments. While both methods could automatically identify the pattern and extent of under-
stress ventricular contraction dyssynchrony, GMPS seemed to be more reliable; since the 
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global cardiac motion was always present in GBPS technique and it was non-separable from 
the endocardial motion and the associated MD. Moreover, the thickening-based approach was 
more accurate and robust than displacement-based measurements in GMPS as it yielded more 
realistic MD findings once the normal subjects were evaluated. Among different parameters of 
the phase analysis techniques, the sensitivity of entropy and CHI/THI was promising in 
specifying the MD variations during the stress conditions not only in the DCM but also in the 
case of normal ventricular anatomy and function.  
2. What is the range of difference in inter- and intraventricular MD parameters when the 
patient is submitted to various levels of functional stress? 
In chapter 1 with control subjects, synchrony of LV contraction in thickening increased from 
baseline to 5 μg/kg/min dobutamine and reached a plateau at 10 ± 5 μg/kg/min dobutamine. In 
chapter 2 with a DCM model, different levels of dobutamine stress, even in close intervals, 
had a significant impact on intraventricular MD parameters and the changing trends were 
mostly seen as going toward the perfection of synchrony. However, inter-subject variability 
and individual differences in the magnitude and pattern of change in interventricular delays 
precluded any definitive conclusion about the effects of dobutamine stress in interventricular 
MD. In contrast to the control group that intermediate levels (5 to 10 μg/kg/min) of 
dobutamine infusion were enough to generate maximum contraction efficiency (reaching a 
plateau), the outset point of MD improvement was 5 μg/kg/min dobutamine for the DCM 
group and it continued through further stress levels. Finally under ventricular pacing in chapter 
3 with AV block model, dobutamine-induced variation in MD was positive at the level of 5 
μg/kg/min dobutamine for all the pacing interventions both in the case of amplitude and 
uniformity of the timing of contraction. However, further stress level up to 20 μg/kg/min 
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dobutamine did not make a considerable change in the phase and amplitude of contraction at 
LV and LVRV20 and even worsened the synchrony of the phase of contraction at BiV, 
RVLV20, and RV pacing modes.  
3. Is the optimal pacing solution at rest in terms of synchrony of contraction also the best 
one during the exercise and increased heart rates? 
The results from Chapter 3 revealed that the mechanical response of the LV myocardium to a 
specific type of pacing intervention might be overestimated or underestimated at rest.  
However, intrinsic physiologic effects of stress resulted in more accurate MD assessments 
with lesser variability in subjects who underwent pacing. The synchrony of contraction both in 
the case of contraction onset within the cardiac cycle (phase) and regional stroke volume 
(amplitude) was significantly improved at a low-stress level in all the pacing modes. While 
further stress did not decrease the homogeneity of contraction in LV and LVRV20 pacing 
modes, it made a significant increase in the entropy of regional contraction in BiV, RV, and 
RVLV20 pacing modes. Hence, greater stress corresponded to a greater contraction 
dyssynchrony whether the stimulation via LV was not applied or was applied at the same time 
with the RV site or by 20 ms delay. In the case of BiV pacing, for instance, earlier contraction 
of the apex and later contraction of the lateral wall at maximum stress made total entropy of 
about 48% relative to the baseline value (46%) showing that higher stress can enforce higher 
discoordination in regional mechanical contraction. In fact, the sequence of induced electrical 
activation affects the myocardial response or the compatibility to the stress condition. BiV 
pacing with pre-activation of the LV closely resembles the intrinsic ventricular activation in 
developing normal mechanical contraction at higher levels of stress and higher heart rates do 
not hamper the activation coincidence between the two sides of the heart, but rather strengthen 
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it, making the synchrony of mechanical contractions more efficient. Overall, although, it was 
hard to find the optimal pacing solution at rest, some differences were lightened up by using 
the stress levels. Therefore, the optimization process of CRT devices is more robust to be done 
in the period of stress or exercise than resting condition that is routinely practiced. Since, 
dobutamine-induced stress may bring about differences in myocardial contractility, making 
stronger evidence to guide on the decision table for any prediction or optimization of response 
to the ventricular pacing.  
 
 The effect of adrenergic stress stimulation on regional LV function and myocardial 
deformation has been previously studied in normal canine and human subjects by tagged-MRI 
technique, mostly with the approach of using stress-MRI method in detecting myocardial 
ischemia.(109-111) A uniform increase in displacement, radial thickening, and circumferential 
shortening was seen in a dose-response pattern from baseline to 10 µg/kg/min dobutamine 
infusion in all those studies without additional increases at higher doses. Thus, similar to our 
finding based on the presence of a plateau in 10 µg/kg/min dobutamine, saturation of 
thickening homogeneity is consistent with the saturation of wall thickening and 
circumferential shortening at this stress level. The reason of such saturation in myocardial 
shortening has been under question. Scott et al.(110) assumed that the decrease of the preload 
(due to lower venous return) and thus a decrease in end-diastolic volume (EDV) in spite of an 
increased contractility could be the reason of lack of improvement in circumferential strains at 
high dobutamine doses. However, we observed no changes in LV EDV, same as the findings 
in the rat study, to support this hypothesis. Daire et al.(111) suggested two possible mechanisms 
for the observed saturation. The first one is based on the shortage of the tagging measurement 
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at higher heart rates in which the duration of the tagging pulse does not change with respect to 
the cardiac cycle and the myocardium tagging no longer occurs in end-diastole but rather in 
mid-systole. Hence a possible underestimation in circumferential shortening might occur at 
high dobutamine levels. They did not apply this hypothesis in their work to see whether 
introducing a trigger delay and tagging preparation at the end of the diastole would obviate the 
saturation. Scott et al. previously thank about the heart rate increase in their MRI study and 
compensated this problem but still found the same results. Thus, based on the findings of our 
first chapter, we advocate from Daire’s second suggestion that successive doses of dobutamine 
may produce a desensitization of dobutamine receptors and consequently an underestimation 
of the dobutamine effect at higher doses (>10 μg/kg/min).(111) 
 The presence of MD in control subjects might seem very odd in the first chapter. How 
could it be possible to have some sort of heterogeneity in LV regional contractions in an intact 
heart? Also, how adrenergic stimulation can to some extent obviate this dyssynchrony? 
Baseline heterogeneity in LV regional and transmural contraction has also been shown in the 
studies performed by high spatial and temporal resolution tagged-MRI techniques.(110,111) A 
number of factors such as muscle fiber orientation, autonomic receptor density, and 
electrophysiologic properties could be involved in observed regional heterogeneity in 
myocardial contraction.(110) Since this thesis uses the pacing intervention in the third Chapter, 
it is pleasant to talk more about the heterogeneity of electrophysiologic properties in detail. 
The myocardial electrical activation sequence (the prerequisite for mechanical contraction) 
and the repolarization time across the LV walls have been extensively studied during the last 
two decades. One of the earliest studies in the human subject was performed by Franz et al.(9) 
that with monophasic action potential mapping in normal subjects suggested the presence of a 
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transmural gradient of repolarization in which epicardium repolarizes before the endocardium. 
With activation proceeding from endocardium to epicardium, they showed a negative 
correlation between the activation time (AT) and the action potential duration (APD). Sites 
with shortest AT had the longest APD in both the endocardium and epicardium. Though, 
progressively later activation was associated with progressively earlier repolarization. 
Although, their findings did not verify any regional ventricular gradient of endocardial AT and 
APD from apex to base or from septal to the lateral wall, they noted that APDs were markedly 
inhomogeneous even within a given region of the LV. The longest average APD was 
measured in the septal and inferior area and the shortest at anteroapical and posterolateral 
sites. Observations by Franz et al. about endocardial heterogeneity in electrophysiological 
properties even in closely adjacent areas were later seen by Cowan et al.(112) in the epicardium. 
However, after pooling data between patients, they found that activation and repolarization 
sequences were opposite in epicardium; meaning activation proceeded from septum to free 
wall and from apex to base, whereas repolarization proceeded from base to apex and from free 
wall to septum.  
 Therefore, a consensus about the presence of a transmural difference in action potential 
morphology and duration was yielded so that APDs were longest near the endocardium and 
shortest near the epicardium and since differences in APD supposed to be greater than AT, a 
transmural voltage gradient toward earlier recovery at epicardium was confirmed.(113) 
However, evidence from the recent studies(114) supported the heterogeneity of the AT-ADP 
relation in the whole human heart. In fact, while the relation of AT-ADP is negative in most 
parts of the LV, positive relations either with early AT and early repolarization time (RT) or 
late AT and late RT could be seen in LV regions.  
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 Data above based on the heterogeneity in electrophysiological properties of ventricular 
myocardium due to the nonuniform expression of ion channels raise the question of how a 
myocardial cell recognize the time of repolarization besides all these heterogeneities within the 
ventricle? One assumption demonstrated by Franz et al.(9) from the earlier studies which then 
was emphasized in recent years(113) is the electrotonic interaction (i.e. ionic changes in the 
membrane of one myocyte can directly influence neighboring myocytes through gap 
junctions) that can relate APD to activation sequence. As mentioned by Franz et al., “During 
the cycle of ventricular depolarization and repolarization, electrotonic current from the area to 
be excited last may retard repolarization of areas excited earlier in the activation sequence, and 
current from the first area to repolarize may speed repolarization in areas not yet 
repolarized.”(9) In diseased hearts, AT-APD relationships are attenuated, and more dispersion 
in RT could be seen in cardiomyopathies.(113)  
 Nevertheless, how dobutamine affects the electrical activation sequence and APDs in 
normal ventricular myocardium? In the human ventricle, John et al.(115)  found a variable 
response of normal myocardium (posterolateral wall of LV and RV side of interventricular 
septum) to dobutamine with either lengthening or shortening of APD. This variable response 
was reported to be as the result of either the dobutamine alpha-beta adrenoreceptor influences, 
mechanoelectrical feedback whereby the force of contraction and degree of stretch alter 
repolarization, or the interactive effects of beta-stimulation on rate-adaptive mechanisms of 
APD. The study by John et al. once again confirmed the baseline electrical heterogeneity of 
regional ventricular myocardium while also showing the heterogeneity of subject response to 
dobutamine stress. The number of subjects was limited (n=7) in their study and action 
potential recording was not performed in several regions of LV myocardium to get to a 
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conclusive response to our question that what is the reason of increased LV contraction 
synchrony with the administration of dobutamine stress? As stated earlier in the introduction 
part, repolarization time is the sum of AT and APD. Though, the positive relationship between 
contraction synchrony and dobutamine might come from the effect of dobutamine stress on 
AT and depolarization gradient, overlooking the APD. Callaghan et al.(116) studied the effects 
of epinephrine, as a catecholamine, and the exercise stress on RV depolarization gradient. 
They concluded that catecholamines decrease the depolarization gradient in a dose-dependent 
response irrespective of underlying baseline pacing rate. Although it might be a notable 
outcome in our way through finding the reason for ventricular stress synchronization, it must 
be mentioned that we did not measure any significant alteration in QRS durations, as a 
depolarization gradient sensor, by dobutamine stress in our three sub-studies. Without a 
sensible decrease in ventricular activation times, nonetheless, increased contractility and 
enhanced contraction synchrony were clearly seen by the induction of dobutamine stress in our 
studies similar to the effect of other catecholamines.  
 It is worthwhile to come back once again to the APD and the study performed by Scott 
et al. in which dobutamine stress quickened the myocardial shortening and thereby obviated 
baseline variations in radial thickening of apical versus basal LV myocardium (apical 
thickening was less than basal thickening at rest).(110)  Electrophysiological properties of apex 
resemble that of endocardium which activates early but has the longest functional refractory or 
repolarization period opposite to the epicardium or LV base.(117) Therefore, it might be 
possible that dobutamine stress stimulation leads to a reduced dispersion in APDs and an 
electrical homogeneity between the levels of LV myocardium (basal versus apical levels) and 
therefore improves the apical thickening and overall LV contraction synchrony. More 
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comprehensive studies about regional LV electrophysiological properties during rest and stress 
are needed for recognition of the causality of ventricular synchronization under stress.   
 Dispersion in repolarization does exist in normal myocardium and its amount is not at 
all sufficient to induce arrhythmias and significant MD as was shown in the first chapter. 
However, in diseased hearts, more dispersion in repolarization time happens and the AT-APD 
relationships are highly attenuated.(113) This phenomenon is accompanied by worsened MD 
even in the presence of normal electrical activation sequence or QRS width as seen in the 
second chapter. Although the underlying pathophysiological mechanisms leading to 
intraventricular MD in the presence of electrical synchrony is poorly understood in humans, it 
seems that regional variability of excitation-contraction coupling and myocardial contractile 
strength are the main problematic factors.(118) Several underlying electrophysiological and 
cellular changes can make those regional heterogeneities.  It has been shown that APD change 
of one beat is inversely associated with the changes in contractility of the next beat.(119) 
Therefore, with respect to the hampered intrinsic property of the myocardium in the adaptation 
of APDs to their related ATs in cardiomyopathies, possible changes in APDs may play a role 
in the variability of myocardial contractile strength.(113,118) Also as further reviewed by Jackson 
et al.,(118) regional variability in multiple cell and molecular pathways including cytokines 
(cardiotrophin-1), calcium handling proteins, gap junction-alpha-1 protein (connexin 43), 
stress response kinases and tissue necrosis factor-alpha expression could be involved in 
excitation-contraction uncoupling and regional heterogeneity of myocardial thickening and 
mechanical contraction.(118) In addition, heterogeneous metabolism(120) and imbalance of 
myocardial blood flow can more fuel the regional heterogeneity in dilated cardiomyopathies. 
Thus, many mechanisms involve in developing dilated cardiomyopathies that can be 
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considered as the underlying mechanisms leading to the MD with the presence of electrical 
synergy.   
 As was shown in Chapter 2, dobutamine stress significantly reduced the variability of 
contraction timing in different regions of left ventricle. Since, the APD, contractility, and 
myocardial strain changes are interdependent factors, and considering the fact that dobutamine 
stress shortens the APDs in the area of weakened contractility properties,(115) it can be 
hypothesized that dobutamine stress improves the contraction homogeneity through reduction 
of the vast disparities in APDs among the LV regions. 
 Although all of MD underlying mechanisms and regional heterogeneities named before 
have been shown to normalize following CRT, it seems that a certain electrical substrate 
(LBBB)(32) is required by CRT to obviate all those problematic MD mechanisms. It means that 
all the mechanisms developed as the result of lacking or delayed electrical activation sequence 
that with induction of the appropriate electrical stimulation, the cellular mechanochemical 
inhomogeneities would disappear and then functional benefits would be conferred in CRT 
candidates. Therefore, although the MD with all of the mentioned underlying mechanisms 
could plausibly be present in patients with DCM and narrow QRS complex, the presence of 
normal excitation-activation sequences interfere with the induced ectopic wavefronts which 
might be harmful to the patients.    
 If we look back to the study performed by Rocchi et al.(48) who showed the superiority 
of exercise stress to rest-echo in predicting LV reverse remodelling and functional 
improvement after CRT, we realize that LV MD had a reduction from rest to the exercise 
stress at non-responders exactly opposite to what was seen for the responders (60±41 ms at 
rest vs 41±43 ms at stress in non-responders and 91±30 ms at rest vs 133±41 at stress in 
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responders). As they reported, 33% (21/64) of non-responders, in spite of possessing CRT 
selection criteria based on the current guidelines, were the patients who showed lesser 
dyssynchrony (or maybe better to say homogenous and improved excitation-activation-
contraction coupling) at stress than rest condition. The role of stress on underlying MD 
mechanisms is not yet clear to explain the dual behavior of stress in the same cohort of 
patients. But what is apparent from the previous studies with narrow QRS patients is that, if 
the stress somewhat improves the MD, it means that the excitation-activation-contraction 
coupling could still be intrinsically established and using the ectopic stimulating fronts would 
not help anymore in this regard. Hence, we believe, as previous studies also suggested,(48,50) 
that one of the methods to dichotomize CRT responders and non-responders even in DCM and 
narrow QRS population could be to look at the LV MD response of the patients to the stress. 
As a note, although, RethinQ(121) and EchoCRT,(30) two multicenter randomized controlled 
trials, are evidence of negative clinical effects of CRT in patients with DCM and narrow QRS, 
there are lines of evidence on the positive effects of CRT in these patients. Thus, many 
definitive hypotheses about underlying MD mechanisms and whether they are potential targets 
for pacing are yet to be tested in this regard. As was seen in our study cohort in Chapter 2, 
lesser stress-MD among DCM subjects may show that establishing an appropriate activation-
contraction coupling is still possible in ventricular myocardium and intrinsic physiologic 
effects of stress help to show this effect. Thus, even if CRT is supposed to help the DCM and 
narrow QRS patients, it will not have assisted in patients with lesser stress than rest-MD. As a 
conclusion, as stated by expert reviewers in 2015,(118) “CRT will have a role in narrow QRS 
patients, but this will be in a minor subgroup with a specific target for benefit with CRT.” Also 
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as they believe, newer advanced techniques such as multisite and endocardial pacing can 
significantly reduce the amount of electropathy, improving the chance of benefit from CRT.     
 In the third chapter, the coordination of contraction between the right and left part of 
the LV myocardium was to some extent lost at higher heart rates, once the LV was paced by 
simultaneous BiV or RV pacing modes. In fact, the reason of the worsened contraction 
synchrony through the maximum level of stress under BiV, RV, and RVLV20 modes, contrary 
to the natural state in the control group, might be faster electrical conduction of the RV 
endocardial cells relative to the distant LV myocardium.(7) Therefore, for the later conduction 
of the signals from LV epicardial site and the fact that naturally the onset of LV activation is 
10 ms before RV endocardial activation,(7,10) BiV pacing with pre-activation of LV closely 
resembles to the intrinsic ventricular activation in developing normal mechanical contraction 
at higher levels of stress. Hence, if the natural sequence of the electrical stimulation is not 
respected, it will be problematic (i.e. increase of MD) at higher heart rates. The mechanics of 
the LV contraction under single- and BiV pacing was previously studied by tagged-MRI. On a 
healthy canine model, it was shown that BiV pacing has a greater impact on correcting the 
spatial distribution of LV contraction than on improving the temporal synchronization of 
contraction.(122) This observation is in agreement with our results based on better temporal 
contraction synchrony with sequential (LVRV20) than the simultaneous pacing. Also, they 
showed that BiV pacing improved the spatiotemporal synchrony of contraction greater than 
RV apical pacing alone.(122) These two pacing modes did not show any significant difference 
in the case of MD and functional parameters in our study. Our results are also in contrast to 
similar dyssynchrony studies,(123-126) measured by echocardiographic methods, on the AV 
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block subjects with normal function, which demonstrated that BiV pacing was superior to the 
RV pacing in the case of SLD.  
 
 This thesis encountered a number of limitations, which need to be considered. The 
number of animals used for each sub-study was limited. While it is always a restriction in 
animal experiments, it can limit the statistical power of the tests used. For this reason, using 
the MHI4MPI as a diagnostic tool for the assessment of MD in particular for the prediction or 
optimization of response to CRT requires more validation. Another constraint for the current 
thesis is the lack of an LBBB model among the models used; since it is amenable to CRT and 
the results of stress-MD assessments could be applicable on its potential target. Also, a non-
ischemic cardiomyopathy model was chosen in the second chapter, since generating similar 
extent of ischemic pathology at all the subjects was difficult. Overall the pathologic model 
used in this study helped us to better understand the relationship between the stress-MD and 
HF. Transferring the methods and findings of this thesis directly to the clinical practice is a 
critical concern. One of the most important issues in this regard is the time of the experiment. 
The gradual increase in the dobutamine stress infusion up to 20 μg/kg/min has been previously 
performed on the clinical basis(110), and no unexpected, and inappropriate side effects were 
encountered in about 20 minutes infusion time. However, using of nuclear imaging techniques 
is totally different than the MRI or the echocardiography. For instance, after 2 minutes of dose 
change in MRI, about four sets of images could be obtained in only 3 minutes at each infusion 
rate. In comparison, at SPECT imaging at least 10 to 15 minutes is required for image 
acquisition at each dose change (at least about 1 hour for total analyses). Therefore, although 
the applied protocol and methodology may seem transferable, they must not be directly used in 
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the clinical study. Instead, if only one safe dobutamine stress dosage like 10 μg/kg/min (which 
develops a plateau at contractility and strain) is selected and the stress versus rest-MD is 
analyzed in the patient, then, the entire imaging techniques and phase analyses for MD 
assessments are completely transferable. Hence with an appropriate stress protocol, the stress-
gated myocardial perfusion SPECT imaging can be performed for the stress-MD assessments 
in place of further CRT optimization or prediction purposes. Finally, low spatial resolution and 
count statistics of the SPECT images remains a limitation. However, there is an ongoing 
project in our group for quantification of MD with the purpose of CRT optimization by 
PET/computed tomography (CT) imaging that with higher tracer counts and better spatial 
resolution can solve the SPECT problem to a great extent. 
 
 One of the future directions for this thesis will be to search about whether the stress LV 
MD indices produced by the nuclear techniques specially GMPS can predict the response to 
CRT.  In the meanwhile, it will be desirable to search for the perfect indicators of LV MD 
(among the MD parameters used in this thesis) at rest compared to stress condition in a large 
subset of CRT candidates. Also, it would be interesting to use the PET/CT system for MD 
assessments and to optimize the patient selection; since it provides a better spatial resolution 
besides valuable information about the tissue viability and leads placement. Thus, further 
prospective clinical studies in which automated assessment of stress-MD being considered, 
can more clarify the relationship between the MD and CRT non-responders.  
 
 As mentioned above, one of the future challenges in our group is to use the gated 18F- 
fludeoxyglucose (FDG) PET/CT imaging for optimization of patient selection, lead placement, 
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and the response to CRT due to its advantages over GMPS imaging. Besides the importance of 
reliable MD assessment, to increase the CRT response rate, it is important that the LV lead(s) 
be placed in regions of viable tissue(s).(127) Although, both the GMPS(33,128) and gated 
PET(127,129) have been demonstrated to assess the LV MD and regional viability for the CRT 
patient selection and LV lead positions, studies on using the gated PET imaging in this field is 
quite limited. In the first part of ongoing research, our primary objective is to validate the FDG 
PET/CT imaging ability to measure the effects of three extremely different pacing modes (BiV 
versus single-site) on LV systolic function and LV intraventricular MD and to see the 
capability of using FDG PET in post-implant CRT programming optimization. Also, the 
assessment of lead placement in the patients receiving BiV pacing helps to identify if the LV 
leads are placed at or near the site of the viable segment with the latest activation.  
 Our preliminary results on three LBBB patients receiving a BiV pacing with LV multi-
leads were satisfactory in showing the pacing-induced differences in function and MD 
parameters.  However, the LV segmentation was not easy to perform in these patients; 2 of 
them had the myocardial area being infarcted and one of them indicated a non-homogenous 
FDG uptake within the LV (lack of uptake in the septum), made it difficult to find the LV 
contour properly. Using the CT images, we were able to mark the place of the LV leads and to 
fuse them into the 3-D FDG viability image. These first findings motivate us towards using 
PET-guided CRT LV lead placement in the cath lab. In fact, before the CRT implantation, an 
FDG PET/CT imaging not only can determine the amount of myocardial MD and scar tissue 
and therefore help in CRT patient selection but also if the patient being a candidate, this 
information would be applicable during the CRT implantation to find the optimal LV lead 
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position. Thus fusion of the fluoroscopy venograms and 3D PET images would guide the 
electrophysiologist to successfully place the LV leads into the target venous site.  
 The first tool-kit was developed in 2014 to reconstruct 3D LV venous anatomy from 
dual-view fluoroscopic venograms and to fuse it with LV epicardial surface on GMPS; it was 
suggested that the 3D fusion method is both technically accurate and clinically applicable.(130) 
The findings also encourage us to start the second part of the study soon which its objective is 
to optimize the interventricular delay in CRT patients. However the acquisition time, once the 
effect of several pacing modes (programming the interventricular delay) is desired to measure 
and the cost, once several episodes of FDG-PET/CT imaging is required for the CRT 
optimization and follow-up are the two major concerns in the discourse. The reduction in 
acquisition time would increase the image noise while longer acquisition time increases 
motion artifacts due to patient movements. Also, the acquisition time might have an impact on 
the quality of final MD parameters derived by phase analysis of the PET/CT imaging. Hence, 
before the first part of the studies, the effect of PET/CT acquisition time on LV MD was 
studied as a prerequisite. In fact, the scanner allows for the selection of a subset of list-mode 
data to perform the image reconstruction based on the chosen acquisition time. Therefore, 
using different acquisition time points of 1, 3, 5, 10, and 15 minutes (as a gold standard) in 41 
HF patients with coronary artery disease, the intra-class correlation coefficient (ICC) indicated 
the lower-level confidence limit > 0.75 (excellent reliability) only at 10 min acquisition for all 
the functional and MD parameters. Therefore, 10 min acquisition would allow us to measure 
the effects of 5 to 6 pacing modes in about an hour. Concerning the cost of imaging for the 
CRT patient selection and follow-up process and also the radiation burden with the serial 
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scans, it is worthwhile to mention that the benefits may outweigh the risk in the end-stage HF 
patients for whom being a CRT responder would be the only chance for surviving. 
 
 In summary, the findings of the current thesis show that the phase analysis of both 
GBPS and GMPS clearly and automatically identify the extent and pattern of ventricular MD 
under dobutamine stress infusion, in a clinical range, either in normal or HF subjects. The 
MHI4MPI software with useful indices and methodologies provided the evidence on the 
superiority of thickening over displacement approach on reliable MD assessments. Different 
levels of functional stress induced significant changes in hemodynamic and MD parameters in 
all of the experimental models used. Also, intrinsic physiologic effects of stress resulted in a 
more accurate MD assessment with lesser variability in subjects underwent pacing. Based on 
the reliable stress-MD assessments with GMPS, BiV with LV pre-activation more resembled 
the intrinsic ventricular activation at higher levels of stress and it was the preferred site of 
stimulation rather than single site pacing in the AV block model with normal function. 
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